annual report terumo group introduced new corporate logo august new logo capture vision standing beginning new stage determined build record important accomplishment even preserve value trust built date curved line extending left right symbolizes rising challenge innovation order provide new value medical frontlines red color signifies life patient passion terumos associate shapecalling mind arc eartharticulates speed action global scale green lettering spelling terumo represents value created point new logo terumo associate across globe work concert ensure living corporate mission contributing society healthcare terumo employee called associate emphasize partnership collaborative working terumo corporation annual report content content editorial policy corporate mission feature article rising challenge innovation message top management business overview financial information corporate governance intellectual property stakeholder environment director audit supervisory board member executive officer major consolidated subsidiary corporate information investor information reporting policy editorial policy report prepared provide stakeholder clear coherent description business activity undertaken fulfill corporate mission contributing society healthcare promote communication society illustration attitude terumo brings fulfilling corporate mission special section provide concrete account interventional therapy reduces burden patient condition surrounding blood transfusion emerging country brochure present mainly information business performance website offer detail environmental social contribution initiative coverage report coverage includes extent possible element global terumo group falling within scope consolidated earnings statement coverage however differs certain instance reporting period report cover activity fiscal april march however recent activity also included note regarding forwardlooking statement report includes information future plan strategy business performance information represents judgment based information available time prepared change economic condition business environment demand currency exchange rate factor therefore may cause actual business performance differ significantly forecast projection terumo corporation annual report courtesy kitasato institute archive terumo corporation founded several scientist doctor including dr shibasaburo kitasato produce clinical thermometer japan vital medical device previously imported cut consequence world war lifelong spirit dr kitasato whose achievement received global recognition found statement scientist never feel selfsatisfaction advanced research true objective result put use thereby contributing society contributing society healthcare terumos starting point unchanging corporate mission keeping dr kitasatos spirit innovation challenge alive strive bring outstanding innovation medicine enable best possible care patient terumo corporation annual report corporate mission contributing society healthcare contribute society providing valued product service healthcare market responding need patient healthcare professional five statement open management maintain fundamental policy open management work secure return benefactor suitable profit strive develop business global basis befits leading company industry enhanced value emphasize importance scientific thinking creativity time appropriation respond depth customer need creating valued product service safety reliability pride commitment development technology quality assurance system ensure safe reliable product respect associate emphasize respect individual promote intercultural understanding encourage openness workplace accordance slogan associate spirit prepare meet challenge future corporate citizenship conduct business activity fair equitable manner act responsibly toward environment fulfill responsibility good corporate citizen terumo corporation annual report feature article rising challenge innovation terumo corporation annual report getting patient cardiovascular disease back daily life quickly possible able get back daily life week go interventional device inserted blood vessel work drive go walk wrist maneuvered heart josias life suburb são paulo brazil long thin balloon metallic tubular mesh routine physical exam december found one structure called stent used open coronary artery blocked cholesterol blocked blood vessel inside substance preventing sufficient involves much less blood loss blood flow march josias underwent traditional approach inserting interventional interventional procedure thin tube device groin even performed called interventional device used open outpatient basis therapy approach gaining blocked artery inside restore popularity throughout world promote use normal blood flow afterward josias received therapy place less physical burden positive prognosis patient terumo offering product training type therapy josias received program use location across globe terumo taking innovation pioneering technology raise therapeutic efficacy stent used treat josias called drugeluting stent de coated drug preventing blood vessel narrowing intervention procedure performed terumo working develop new method applying drug stent creating stent better property extending boundary de technology way well latest drug gradually released take effect new generation stent development incorporated new de introduced resorbed inside body european market june meanwhile ongoing development focusing commercialization new generation stent bioresorbable scaffold resorbed inside body medical professional terumos technology clearly stand market patient used terumos drugeluting coronary stent display favorable clinical result one could say terumos continuous investment prof dr expedito e ribeiro research development contributing greatly associate professor cardiology delivery therapy provides better outcome university são paulo brazil lower physical stress patient director interventional cardiology totalcor hospital sp terumo corporation annual report feature article rising challenge innovation terumo corporation annual report system enhance safety medical professional handling anticancer drug cancer chemotherapy anticancer drug used accidental exposure anticancer drug suppress proliferation cancer cell anticancer wellknown time strict measure drug however destroy cancer cell taken mitigate measure however also side effect damage normal cell yet sufficiently implemented japan cause serious health problem include terumo began selling closed infusion system leukemia infertility healthy people enables safe handling anticancer drug congenital birth defect pointed japan asia respectively health risk particular concern system employ various innovation reduce pharmacist nurse prepare anticancer drug spraying splashing leaking handling administer patient normal part anticancer drug work u europe risk associated terumo taking innovation training healthcare professional anticancer drug exposure prevention terumo conduct practical training inform medical professional health risk arise spraying splashing leaking anticancer drug provide instruction mitigation measure developing shared awareness measure among medical professional involved treatment cancer recognized enhancing safety handling training exercise using fluorescent dye closed infusion system focusing anticancer drug also resulting better care patient simulate spraying splashing safety step preparation ministry health labour welfare may leaking anticancer drug administration anticancer drug notification prefectural government safety measure handling anticancer drug expected boost awareness important topic cancer treatment setting japan medical professional terumos anticancer drug infusion system various innovation reduce spray splashrisks nurse previously careful preparing administering anticancer drug oncology nurse become ill handling anticancer drug would negative impact patient care significant damage sachiko tachibana operation hospital work considering vice president head nursing university fukui hospital health safety individual medical personnel therefore ultimately protects patient hospital alike terumo corporation annual report feature article rising challenge innovation terumo corporation annual report providing safer blood product patient developing nation africa blood product used transfusion often period time blood collection recent year contain residual white blood cell pathogen terumo focused understanding virus bacteria example ghana pathogen reduction technology prt system could whole blood product contaminated used improve safety blood product bacteria contain malaria plasmodium developing nation terumos prt system u parasite africa whole estimate ultraviolet light riboflavin vitamin b naturally new hiv infection due unsafe occurring substance reduce pathogen load blood global level world health organization virus eg hiv bacteria parasite eg malaria belief better blood safety strategy inactivate residual white blood cell system could prevent new case hiv annually already used several developed county testing pathogen africa prevalent process platelet plasma product existing testing method always adequate terumos prt system conformance medical device directive available select market however terumos prt system detect bacteria virus dormant sale u terumo taking innovation reduce pathogen load blood product make safe patient terumo embarked clinical trial ghana support future implementation prt whole blood transfusion believe prt system prove valuable resource patient developing nation terumos pathogen reduction technology prt system medical professional clinical trial provide evidence may greatly advance provision safe blood ghana developing country terumos prt system shown effective could significantly improve safety whole blood maternal hemorrhage malarial anemia dr shirley owusuofori transfusion medicine specialist many clinical condition hopeful head transfusion medicine terumos prt system minimize residual risk unit komfo anokye teaching hospital highprevalence infection pathogen malaria universal screening currently exists terumo corporation annual report message top management continuing contribution globalized healthcare terumo established improve public health making highquality thermometer today motivation life corporate mission contributing society healthcare globalization healthcare driving major change way contribute continue quest deliver new value patient healthcare professional throughout world yutaro shintaku president representative director terumo corporation annual report recap fiscal fiscal agenda accelerating growth boosting profitability fiscal factor including health insurance reform revision reimbursement price japan u fiscal austerity europe perpetuated additional outlay quality management system downward pressure healthcare expenditure developed improvement fiscal particularly challenging country time ongoing growth demand profit front response effect swift course medical service emerging country blunted correction aimed achieving high growth profitability growing pressure keep price initiative discussed difficult condition however terumo continued grow contributing greater safety change operation globalized businessled efficiency medical service providing therapy management improve medical cost efficiency reduce burden patient employed matrixstyle management cardiac vascular business example introduced approach business segment along vertical axis new product interventional therapy application function region horizontal april however expand coronary brain lower adopted globalized businessled management organized extremity laying groundwork launch around three core company cardiac vascular company new coronary intervention product early fiscal general hospital company blood management looking future technology reduced stress company nine division blood vessel also acquired exclusive acquisition right company manage sale rd production function clarify french venture company developing product profit responsibility speed decision making part general hospital business introduced addition global management key underlying range new product including enhancement theme division headquarters already located offering safely administering drug system equipped place make sense pursuing rd data communication function prevent medical accident production marketing strategy globally device improve efficiency medical setting cardiac vascular company example blood management business globally expanded interventional system division charge product system efficiently process blood preparation interventional therapy coronary heart lower broadened application therapeutic apheresis extremity based japan neurovascular strengthening rd also moved ahead plan create division led u subsidiary microvention inc cv robust production system measure system division overseeing activity field cardiac establishment new factory vietnam surgery headed another u subsidiary terumo result activity discussed recorded cardiovascular system corp vascular graft division fiscal net sale billion yen year year handle artificial vascular graft used surgical operating income billion yen year year therapy led uk subsidiary vascutek ltd challenge faced include delay ramping general hospital company continue based manufacturing cost reduction new product japan blood management company continuation investment improve quality operation pursued terumo bct inc also management system overseas factory u subsidiary terumo corporation annual report message top management new globalized businessled management new system based matrix management three company nine division cardiac vascular region function division region function neurovascular division cardiac vascular cv system division vascular graft division general hospital general hospital region function blood management general hospital product division dm consumer healthcare division corporate pharmaceutical nutrition division dd division blood management region function corporate corporate head office meanwhile develop aiming achieve growth profit margin target implement portfolio strategy corporatewide development sale new product transfer perspective enhance corporate function putting production location outside japan activity place infrastructure support global business activity centered mainly division recently june three core company released new drugeluting stent de ultimaster european market neurovascular division accelerate shift highermargin product focusing new neurovascular intervention device new businessled management approach aim expanding highly profitable dm consumer increase value add strengthening position healthcare division dd division primary focus company area specialty boost profit revising general hospital company also set production system furthermore measure aimed rebuilding reducing cost business profit strengthening increasing efficiency corporate suffered established business structural improvement function corporate head office aim accelerate office also move ahead plan transfer improvement profitability production place outside japan specific level cardiac vascular company blood management company expand business terumo corporation annual report therapeutic apheresis cell therapy promise future market expansion shift production product global csr initiative including blood bag asia reduce cost meanwhile corporate head office work revamp furtherance corporate mission contributing logistics lower procurement cost newly society healthcare advance communication established procurement dept promotes even greater trust understanding stakeholder customer shareholder employee write asset certain business supplier local community pursue social general hospital company pharmaceutical nutrition environmental initiative business activity division cardiac vascular company cv system csr activity strengthen group legal division recorded extraordinary loss previous compliance system quality management system fiscal year current fiscal year take production setting formulate terumo global ehs inventory business facility step boosting environmental health safety policy take corporate value long term preparing growth action well emphasize global outlook also push ahead development major longterm objective terumo group new product future continue search become company global presence realizing opportunity key people working foster sense fiscal year securing foothold corporate culture recognizes diversity viewpoint taking decisive step lead future growth promotes development people spirit nearterm goal committed achieving challenge new idea source innovation operating margin excluding goodwill amortization contributing betterment healthcare etc fiscal direction moving step taking achieve objective described detail operating profit margin target annual report drawing capability aim achieve sustainable profitable growth contribute global healthcare continuous support greatly appreciated move forward fiscal fiscal fiscal result forecast outlook operating profit margin amortization goodwill intangible shareholder return aim pay dividend steadily increase reflecting factor performance future investment plan goal mediumtolong yutaro shintaku term call dividend payout ratio president representative director terumo corporation annual report participation united nation terumo became signatory united nation global compact action reflects terumos agreement ten principle compact relate human right labor practice environment anticorruption measure terumo given shape mission contributing society healthcare setting five statement formulated principle guide group global business development make valuable contribution healthcare worldwide going forward terumo continue fulfill responsibility global enterprise aiming achieve sustainable growth ten principle united nation global compact human right principle business support respect protection internationally proclaimed human right principle make sure complicit human right abuse labor principle business uphold freedom association effective recognition right collective bargaining principle elimination form forced compulsory labor principle effective abolition child labor principle elimination discrimination respect employment occupation environment principle business support precautionary approach environmental challenge principle undertake initiative promote greater environmental responsibility principle encourage development diffusion environmentally friendly technology anticorruption principle business work corruption form including extortion bribery terumo corporation annual report business overview business overview cardiac vascular company general hospital company blood management company terumo corporation annual report business overview terumo rising challenge innovate three business area terumo contributing society healthcare pursuing business activity three company provide optimal product service medical setting world pursuing higher quality medicine introduce improvement greater safety ease use conduct training promote proper usage device propose system responding comprehensively need medical setting net sale company blood division management company billion yen billion yen cardiac pharmaceutical vascular company nutrition division fiscal billion yen general billion yen billion yen dd division hospital company billion yen billion yen neurovascular division billion yen dm consumer healthcare division cv system division billion yen billion yen general hospital product division billion yen vascular graft division billion yen interventional system cardiovascular system net sale geographic area asia others overseas billion yen japan billion yen europe billion yen fiscal billion yen billion yen america billion yen terumo corporation annual report cardiac vascular company cardiac vascular company strives make interventional procedure surgery treating heart type vascular disease less burden patient cholesterol substance build inside wall blood vessel due cause including lifestyle disease eventually result heart attack angina treated using intervention device open blocked blood vessel inside known coronary intervention surgically opening chest using section blood vessel another part body artificial blood vessel go around location blockagebypass surgery cardiac vascular company strives reduce burden patient improve therapy outcome recently endeavor also come include treatment vascular disease brain lower extremity general hospital company general hospital company contributes higher quality medicine large providing medical device pharmaceutical system designed improve safety convenience medical treatment setting diversified extend hospital patient home medical device pharmaceutical therefore must incorporate performance usage design consideration tailored setting used general hospital company offer series system comprising combination device pharmaceutical optimized patient providing care company provides added value system form greater safety setting medical treatment provided improved efficiency performing treatment procedure blood management company blood management company drive customer value enhances patient outcome blood component therapeutic apheresis cellular technology global leader blood component therapeutic apheresis cellular technology company unique combination apheresis collection manual automated whole blood processing pathogen reduction believe potential blood even patient today belief inspires innovation strengthens collaboration customer terumo corporation annual report business overview cardiac vascular company vigorous rd strategic alliance creating valuable solution solidifying presence global market shinjiro sato president cardiac vascular company fy result net sale business billion yen net sale region billion yen net sale billion yen vascular graft asia others japan cv system fy fy operating income billion yen neurovascular europe america operating profit margin fiscal result interventional therapy performed entering blood vessel wrist terumo strongly promoting sale growth led business neurovascular division achieved doubledigit sale growth strong performance growthdriving addition scepter occlusion balloon catheter neurovascular division cardiac vascular company posted fred flow diversion stent new product along yearonyear increase net sale billion yen mainstay coil treating cerebral aneurysm japan misago peripheral stent hiryu plus turning profit ongoing investment cv system balloon catheter coronary intervention new division improve ann arbor plant quality management therapeutic device led increase sale system line u food drug administration fda outside japan strong sale growth u standard weighed heavily profit nevertheless europe emerging market combined positive divisiona key profit centerrecorded significantly higher exchange rate impact produce increase sale profit result sale growth strict cost control notably strong growth despite global price decline negatively affected neurovascular division division benefitted mainly business condition addition positive exchange growing popularity tri transradial intervention rate impact division strong performance growth forecast neurovascular division neurovascular coilassist stent flow million dollar diversion stent occlusion balloon peripheral sfa stent carotid artery stent pta balloon coronary new de new ptca balloon access device guidewires etc fy terumo corporation annual report cardiac vascular company booked overall increase strategy going forward profit billion yen margin pursuing sustainable profitable growth building global capacity key fiscal initiative first priority pursuing sustainable profitable growth strengthening core business develop business key growth field area pursuing strategic alliance coronary intervention new ultimaster de launched fiscal year significant progress implementing june europe part asia result innovative growth strategy particularly division drugeluting design ultimaster offer exceptional deliverability stent de comprise largest segment conformability contributes longterm clinical outcome interventional device market also key product little burden surrounding blood vessel heading division entered market nobori stent toward scheduled start japan sale fiscal working ultimaster stent next product ultimaster subject marketing effort reflect another step forward taken fiscal toward expectation significant earnings developing latter granted ce mark enabling neurovascular division global expansion stent commencement european sale fiscal balloon product launched fiscal followed looking future terumo joined series market introduction new product currently development new type stenta drugeluting development taking place several year bioresorbable scaffold name implies introduction aimed maintaining high growth resorbed inside body eventually leaving foreign next priority undertake sweeping reform substance specific term entered joint improve profitability improvement profitability development agreement proprietary coating cost management important global trend technology used new bioresorbable scaffold price pressure farreaching improvement project achieve development arterial remodeling technology sa art competitiveness global market already moving forward france part agreement also obtained exclusive division mainstay ashitaka factory acquisition right art third list priority strengthening quality another area mediumto longterm growth management system production percentage expected endovascular intervention signed sale volume u market rise global basis joint development agreement kaneka corporation becoming important quality management japan related move also entered cooperation system comply latest fda standard cv agreement fmd co ltd another japanese company system division ann arbor factory meant radical facilitate access market therapeutic guidewires improvement response fda finding agreement expected open door hopeful effort pay fiscal broad range product significant step toward fourth priority evolution global management achieving competitive advantage field approach cardiac vascular company consists four endovascular intervention division global headquarters function fiscal also year important progress responsible operation also financial global production strategy first two important performance market outside japan accounting action moved forward strategic shift roughly sale cardiac vascular company interventional device manufacturing expanded already operating condition business vietnam factory lightening burden mainstay competitiveness determined efficiency global ashitaka factory improving cost competitiveness operation therefore currently working globally second expanded production capacity strengthen company supply chain management factory costa rica opened fiscal cardiac vascular company strives remain abreast manufacture product highgrowth neurovascular global trend cuttingedge medical device division enhanced capability meet expanding provide solution offering new value continue investing global demand provide cost benefit internal development also actively pursuing strategic alliance opportunity order extend competitive advantage going forward drugeluting coronary artery stent ultimaster occlusion balloon scepter terumo corporation annual report business overview cardiac vascular company cardiac vascular company contributes cuttingedge treatment including cardiac vascular surgery interventional procedure performed inside blood vessel pursuing therapy minimize physical burden patient interventional therapy performed tri blood vessel wrist coronary artery lesion tri reduce physical burden patient performing interventional therapy increasing number practitioner recent year adopted stent deployed approach gain blood vessel access site lesion wrist rather groin terumo offer device training specialized introduce interventional device approach via artery wrist providing comprehensive solution every step blood vessel access treatment type interventional device intravascular imaging system combined access device enables blood vessel access guide lesion intravascular imaging system used therapeutic device delivered system confirm intravascular condition use therapeutic device access device introducer sheath guidewires guiding catheter therapeutic device intravascular balloon catheter stent ofdi intravascular ultrasound system imaging system ivus terumo corporation annual report optimizing cardiovascular surgery applying interventional technique approach cardiopulmonary bypass system perform therapy entire body cardiac vascular company provides artificial cardiac vascular company u technology coronary vascular graft used cardiovascular surgery intervention expand line product performing system temporarily perform function neurovascular intervention therapy peripheral intervention heart lung cardiovascular surgery lower extremity procedure improving performance device helping make surgery less physically stressful patient neurovascular intervention cardiopulmonary bypass system cerebral blood vessel coil made platinum stent used prevent cerebral arterial filter aneurysm rupturing oxygenator causing subarachnoid hemorrhage coronary intervention coronary blood vessel heartlung machine balloon stent used improve coronary blood flow directly opening holding coil used treat cerebral open coronary blood vessel aneurysm help maintain circulation blood become blocked gas exchange cardiovascular surgery buildup cholesterol substance peripheral intervention peripheral blood vessel balloon stent used drugeluting stent restore blood flow peripheral eg leg blood vessel become blocked oxygenator heartlung artificial thoracic integrated arterial machine vascular graft filter temporarily temporarily used replace substitute substitute disease portion lung oxygenate heart circulate blood vessel peripheral stent blood blood primary product business field basis entire terumo group please note product availability may differ region terumo corporation annual report business overview general hospital company enhancing line highvalue added product improve safety efficiency medical setting improve profitability hiroshi matsumura president general hospital company fy result net sale business billion yen net sale business billion yen dm consumer general hospital net sale billion yen healthcare product asia others japan dd europe fy fy operating income billion yen pharmaceutical nutrition america operating profit margin fiscal result making improvement earnings structure key issue going forward earnings structure improvement key issue fiscal sale increase general hospital key fiscal initiative company dd drug device division provides advancing area strategy diversifying prefilled syrinx pharmaceutical product added value enhanced combination drug market need medical device dm diabetes management mounting pressure control medical expense consumer healthcare division helped boost overall net developed country medical device manufacturer must sale year year billion yen focus providing product deliver performance earnings however declined cause quality also contribute healthcare economics unfortunate development sale impact delay japan account half general hospital getting new product ground mainstay general company net sale need growing amid hospital product division developing business expanding market eldercare product service around infusion product effect lower contribute longterm care medicine contrast emerging productivity overseas factory operating margin market improving medical infrastructure operating income amortization depreciation generating growing demand medical device general divided net sale declined year ago responding diversifying need general hospital nanopass sale cumulative nanopass sale surpass billion unit million yen fiscal fiscal nanopass nanopass g introduced g introduced x million yen fiscal sale million yen fy terumo corporation annual report company putting forth strategy tailored strategy going forward characteristic individual market achieve greater focusing improving profitability earningsyielding business performance expanding offering highvalueadded turning review main fiscal development business japan core general hospital product product division introduced new infusion syringe pump general hospital company work reduce production product data communication function cost mainstay product transform sale prefilled syrinx performed steadily highvalueadded business centered medical safety product sold directly hospital sold steadily implement strategy company adopt partnership pharmaceutical company together management approach integrates development pharmaceutical company partner terumo developing production sale emphasizes speed execution prefilled syrinx optimized ease use safety initial step company established administration stable storage delivery without impacting business structural improvement office restore profitability quality taking characteristic drug mainstay general hospital product pharmaceutical usage consideration specified customer nutrition division regard general hospital dm consumer healthcare division recorded product division particular transfer production higher sale blood glucose monitor painminimizing factory china philippine asian location nanopass g insulin injection needle expanded emphasize quality profitability meanwhile area cancer treatment growth strategy general hospital company postoperative pain management dd division launched enhancing offering new product group field acelio intravenous injection mg first intravenous requiring highvalueadded product mainstay general injectable acetaminophen antipyretic analgesic enter hospital product division currently working boost japanese market working expand business productivity expand sale surflo v iv catheter acetaminophen available japan oral infusion therapy safety feature surplug ad series medication suppository child palliative closed infusion system infusion syringe pump data care however concluded acetaminophen communication function help ensure correct drug infusible form necessary terumo asked administration along new valueadded product ministry health labour welfare develop contribute efficiency accident prevention product expectation new intravenous medical setting product offered injectable acetaminophen permit appropriate pain individual component system bring greater overall management also oral administration suppository safety convenience medical setting reduce cost practical postoperative care use cancer patient effort made expand adoption overseas operation lowreturn business europe chemoshield anticancer drug administration system north america reviewed part business reduce risk oncology nurse come direct portfolio restructuring general hospital product exposure anticancer drug pharmaceutical division infusion pump intravenous needle led nutrition division attention focused strengthening sale increase asia central south america nutrition business includes new mermed regarding capital expenditure production line semisolid food product case gastroesophageal prefilled syrinx fujinomiya factory expanded reflux concern terumeal series caloriedense investment made boost production glucose food product oral consumption monitoring related product kofu factory dd drug device division growing market investment made building production segment working develop business continuing facility new yamaguchi factory work expand domestic market share proprietary product proceeding toward operational startup overseas investment accelerating global strategic alliance area pain made expand production syrinx factory management growth effort focused acelio philippine achieve lower cost maintaining quality intravenous injection mg acetaminophen product discussed dm consumer healthcare division also growth driver striving boost market share hr joint line glucose body temperature blood pressure monitor equipped data communication function time working achieve greater adoption nanopass g needle surflo v iv catheter terumo corporation annual report business overview general hospital company general hospital company strives improve safety ease use therapy device used hospital home enhancing safety drug administration infusion system infusion system used throughout hospital ward intensive care unit terumo develops infusion system offer greater safety helping ensure use right drug right amount reducing risk airborne contamination accidental needle stick systembased drugadministration safety infusion solution designed prevent infusion pump administration without proper installed drug library preparation infusion help prevent mistake flow solution bag rate infusion line connector iv catheter closed infusion system engineered prevent leak prevention airborne accidental needle stick contamination drug device dd combining drug medical device technology general hospital company provides product enable safe handling multiple drug even emergency medical setting prefilled syrinx prefillable syringe prefilling syrinx drug enhances terumo custom develops syrinx safety administration drug suit characteristic biopharmaceuticals drug used administer terumo corporation annual report bringing greater efficiency daily care measuring device system nutritional supplement communication function general hospital company provides product optimized system centrally manages patient data required daily term nutritional content form palatability people treatment contributing efficient nursing care risk special nutritional need arising hospitalization management advanced age factor designed simplify preparation product also consider need caregiver condensed liquid meal condensed liquid meal blood glucose meter blood semisolid oral intake pressure monitor formulated viscosity water product come variety thermometer content level addressing flavor making appropriate communication functionality gastroesophageal reflux use entrée type enhances efficiency hydration need meal item management vital sign giving peace mind people battling cancer pain management closed anticancer drug infusion system general hospital company provides medication infusion system designed prevent direct contact supporting treatment cancer patient anticancer drug preparation administration terumo offer line allow pharmacist nurse involved provision pharmaceutical consisting chemotherapy perform job without fear exposure various analgesic including powerful drug opioids administered dosage anticancer drug infusion adjusted individual pain level system antiemetic suppress nausea system mitigates risk administration direct exposure anticancer anticancer drug addition drug every step drug product preparation administration offering wide assortment drug original generic also help lighten drug analgesic antiemetic cost patient primary product business field basis entire terumo group please note product availability may differ region terumo corporation annual report business overview blood management company global leader proven financial track record history driving customer value enhancing patient outcome david perez president blood management company president ceo terumo bct inc fy result net sale business billion yen net sale business billion yen collection net sale billion yen cell therapy etc blood component asia others japan fy fy operating income billion yen whole blood collection europe america operating profit margin component developed market due patient blood unlocking potential blood management initiative slower pace regulatory terumo bct global leader blood banking transfusion approval healthcare cost containment initiative medicine cellular therapy industry strong powerful market forceswe continued grow history innovation quality service combined strengthen business steadfast commitment associate proud announce business grew rate stakeholder customer country patient outpaced competitor increased sale ultimately serve yearonyear billion yen increased twice rate sale growth increased cash flow fiscal result increased sale profit even fiscal key strategy challenging environment focused protecting extending market share fiscal set ambitious goal worked hard developed market expanding presence achieve even many challenge facing developing market achieving strong growth africa asia healthcare industryincluding reduced demand blood eastern europe latin america middle east blood management company net sale sustained profitable growth long term growth continues fiscal fy net sale fiscal earlier total premerger sale terumo transfusion cardianbct actual foreign exchange rate used past year projected rate used fiscal terumo corporation annual report leveraged product portfoliothe expand product portfolio one example new agreement comprehensive industryand diversified therakos inc serve exclusive distributor australia strategic alliance launch several new product new zealand six latin american county innovation pipeline customer developed developing country starting invest newly innovation leverage comprehensive portfolio introduced whole blood automation pathogen innovation pipeline reduction technology also grew therapeutic company built listening collaborating apheresis cell processing business worldwide global customer research product development innovation practice helped pave way continued strengthen manufacturing capability nextgeneration application future innovation increasing production capacity controlling cost fiscal innovation development budget providing excellent service customer worldwide increase approximately addition increasing investment innovation taken measure improve process driving faster timetomarket strategy going forward better aligning new nextgeneration technology looking forward strong growing profitable market trend sale growth challenging given difficult market dynamic organization poised grow faster global manufacturing strategic strong overall market competitor within industry uniquely positioned deliver established strategy longterm sustainable profitable exceptional service customer across globe growth proven successful marketplace continue implement comprehensive global remain committed continue listen manufacturing strategy several key expansion designed customer deliver product meet need increase production enhance business continuity lower need blood donor patient serve cost new fdacertified facility opening vietnam expansion u india northern ireland underway market share protect extend expand ability manage cost good productivity continue protect extend market share efficiency never stronger developed market japan north america western europe expanding presence developing market diversification support expand eastern europe latin america middle east three established core businessesblood center southeast asia tiered approach help offset decreasing therapeutic apheresis cell processingour company demand blood created patient blood management brings wide range solution market initiative developed area opportunity continue focus supporting area optimistic sustainable profitable growth developing region rapid growth area cell processing based work increase adoption accessibility clinical progress validate use cell therapy treat therapeutic apheresis area neurology nephrology complex difficult widely prevalent disease like cancer hematology immunotherapy technology offer heart disease diabetes promise wide range disease also continue drive global adoption whole blood automation challenging time global economy pathogen reduction cell processing technology also exciting era organization potential wellestablished global infrastructure provides blood virtually unlimited potential terumo bct foundation business development activity foreign exchange rate neutral headquarters u state colorado vietnam factory completed july terumo corporation annual report business overview blood management company offer system highquality efficient collection processing donated blood global basis furthermore expanding application apheresis system employ outstanding centrifugal separation technology providing patient new option treating various blood disease enabling highquality safe transfusion need blood transfusion people experienced significant loss blood wholeblood transfusion performed many type surgery treat victim serious accident people disease prevent people disease prevent body making enough blood production healthy blood disease patient become deficient disease leukemia thrombasthenia blood component diminished bone abnormality marrow function treated transfusion production blood component treated blood component blood therapy component collection whole blood collection device allows blood center contributes transfusion medicine safe efficient safely efficiently collect highquality collection processing donor blood needed blood component u single needle repeated draw return phase isolates main blood component continuous centrifugal separation technology making possible collect platelet plasma return red blood cell blood bag system leukocyte reduction filter automated blood collection system automated blood component processing system terumo corporation annual report pathogen reduction technology inactivating pathogen residual white blood cell evade pathogen reduction detection blood product technology contributes greater technology system safety blood transfusion available sale japan providing new option treating intractable disease blood therapy cell expansion therapeutic apheresis technology functionally closed hollowfiber bioreactor technology enables broad range customizable streamlines cell expansion reproducible scalable procedure including therapeutic automated process specifically designed address space exchange depletion performed challenge labor demand associated cell therapy highlevel automation development system also reduces contamination risk doesnt sacrifice flexibility associated manual expansion control operator need achieve procedure outcome system also enable adaptable cell collection cell therapy high yield transplantation well cell processing technology monocyte enrichment versatile cell washing concentration therapeutic apheresis system cell expansion system primary product business field basis entire terumo group please note product availability may differ region terumo corporation annual report financial information fiveyear financial summary consolidated financial information consolidated financial statement terumo corporation annual report fiveyear financial summary consolidated terumo corporation consolidated subsidiary fiscal year ended march million yen fy fy note fy fy fy fiscal year ended march ended march ended march ended march ended march net sale operating income income tax minority interest net income net cash provided used operating activity net cash provided used investing activity free cash flow net cash provided used financing activity research development expense capital expenditure depreciation amortization note per share indicator note yen earnings per share eps dividend book value per share bps fiscal year million yen current asset current liability working capital total asset net asset capital management indicator roe roa shareholder equity ratio share outstanding end fiscal year thousand employee end fiscal year note including amortization goodwill stock split carried terumo common share effective april information purpose figure net income per share net asset per share adjusted reflect would stock split carried beginning fiscal fiscal year end five asian consolidated subsidiary changed march december result fiscal company lasted total month starting january ending march change fiscal year end effect increasing net sale million yen operating income million yen ordinary income million yen net income million yen fiscal terumo corporation annual report financial information net sale income net sale net sale japanoverseas compared previous fiscal year net sale increased billion yen billion yen amount net sale japan came billion yen yearonyear reflecting ongoing sale growth blood glucose monitoring system general hospital company well improved result misago peripheral stent new percutaneous transluminal coronary angioplasty ptca dilation catheter cardiac vascular company business increased sale fy automated blood component collection system blood change fiscal yearends consolidated subsidiary march december bag blood management company outside japan order unify fiscal yearend consolidated group member added billion yen overseas net sale fiscal net sale jumped billion yen yearonyear driven increased sale automated blood component collection system business expansion emerging country blood management company strong operating incomeoperating income amortization goodwill intangiblesoperating profit margin performance business particularly america amortization goodwill intangible billion yen gross profit gross profit totaled billion yen increase compared previous fiscal year improved profit due depreciating yen expanded lineup highly profitable product cardiac vascular company blood management company offset delay ramping sale new product general hospital company yielding overall growth fy operating income goodwill intangible refers goodwill marelated intangible asset arising acquisition cardian bct excludes reveosrelated rd asset definition set forth segment information fiscal earnings report operating income jumped yearonyear billion yen despite increase rd expense general administrative expense included investment intended foster business growth operating income net incomeroe billion yen grew result higher sale gross profit benefit depreciating yen net income net income decreased yearonyear billion yen decrease mainly due impairment loss noncurrent asset resulting nonprofitable business facility despite extraordinary income billion yen settlement received fy terumo corporation annual report financial information result business segment cardiac vascular company fiscal net sale business segment japan cardiac vascular company boosted sale expanding product range individual therapeutic cardiac vascular company billion yen field example included misago peripheral stent neuro cv vascular total vascular system graft hiryu plus ptca dilation catheter interventional system japan outside japan business continued generate america strong result tri grew popularity north america europe neurovascular business sale new product asia stent expanded globally others result activity cardiac vascular total company recorded yearonyear increase net sale billion yen general hospital company general hospital company billion yen japan delay ramping sale newly released pharma general dm ceutical infusion systemsrelated product negative impact hospital dd consumer total product healthcare nutrition sale profit sale prefilled syrinx product japan related blood glucose monitoring system continued america grow driving overall sale yearonyear outside europe japan sale expanded country asia result asia factor net sale general hospital company others rose compared previous fiscal year reaching total billion yen blood management company competition intensified japan sale product blood management company billion yen whole blood collection automated blood collection cell whole blood blood therapy total component collection system increased driving component collection etc overall sale yearonyear outside japan patient japan blood management program negatively impacted america demand europe united state sale new europe automated blood component processing system still asia others managed expand europe sale automated blood component collection system continued grow total emerging country owing factor net sale blood management company rose yearonyear billion yen terumo corporation annual report balance sheet cash flow information total asset total assetsroa total asset rose billion yen billion yen billion yen primary factor behind increase included acquisition property plant equipment increase market valuation investment security exchange rate impact liability liability increased billion yen billion yen change due primarily billion yen increase income tax payable fy total net asset total net assetsshareholders equity ratio net asset increased billion yen billion yen billion yen contributing change billion yen increase retained earnings billion yen increase valuation difference availableforsale security foreign exchange impact net cash provided used operating activity net cash provided operating activity came billion yen compared billion yen provided fiscal income income tax totaled billion yen fy depreciation amortization billion yen amortization goodwill billion yen income tax paid net cash provided operating activity billion yen billion yen net cash provided used investing activity net cash used investing activity came billion yen compared billion yen used fiscal outlay billion yen property plant equipment primary factor contributing result net cash provided used financing activity net cash used financing activity came billion yen fy compared billion yen used fiscal billion yen net decrease shortterm loan payable cash flow billion yen primary factor contributing result fiscal fiscal change net cash provided used operating activity net cash provided used reflecting result discussed cash cash investing activity equivalent end fiscal year increased net cash provided used financing activity billion yen end prior fiscal year cash cash equivalent billion yen consolidated basis year end terumo corporation annual report financial information rd activity cardiac vascular company commenced sale rd expense glidesheath slender sheath tri united state billion yen along flowdiverting stent occlusion balloon neurovascular intervention market japan europe company also obtained ce mark certification ultimaster drugeluting stent february began sale europe june aim expanding future product pipeline company secured exclusive acquisition right arterial remodeling technology sa french company developing bioresorbable stent concluded fy agreement pursue joint development series investment terumo also investing emergent medical partner ii lp u venture capital fund effort rd expense business segment gain latest technological expertise company blood management cardiac company vascular company transferred development project incubator billion yen billion yen center started initiative achieving rapid commercialization result activity fiscal rd billion yen expense came billion yen net sale general hospital company billion yen cardiac vascular company company rd work consists research total rd expense fiscal include billion yen basic research conducted rd headquarters cannot reasonably apportioned various company development interventional system cv product led terumos rd headquarters terumo cardiovascular system corporation research development launch status fiscal pipeline product neurovascular product led microvention inc field product region cardiac vascular company rd expense totaled peripheral stent knee japan billion yen fiscal year coil assist stent china neurovascular flow diversion stent europe general hospital company occlusion balloon japan led terumos rd headquarters research new ptca balloon japan development work performed product coronary ofdi intravascular imaging system japan infusion device infusion fluid prefilled syrinx digital slenderized introducer sheath tri u thermometer digital blood pressure monitor renal sympathetic denervation system rsd europe ablation general hospital company rd expense totaled rsd tri technique europe billion yen fiscal year automated blood component processing europe system prp method automated blood component processing europe blood management company blood system bc method management rd work company consists research data management system europe tacsi application development performed primarily terumos rd therapeutic apheresis system japan headquarters terumo bct holding corporation bone marrow stem cell application transfusionrelated product needless system japan blood management company rd expense infusion system safety iv catheter u asia totaled billion yen fiscal year smart pump infusion syringe pump europe terumo corporation annual report business risk following risk factor could negatively impact terumos risk associated overseas operation operating result financial position terumo supply product country possible market terumo serf recession change government healthcare policy resulting contraction demand unanticipated healthcare industry government japan political instability sudden imposition government overseas continue restrain healthcare cost regulation country could impact company implement reform intended raise quality operating result financial position healthcare large unforeseen change government healthcare policy terumo cannot respond could quality control affect company operating result financial position terumo manufacture product based stringent quality control principle accordance market price fluctuation good manufacturing practice gmp standard part measure restrain healthcare cost japan pharmaceutical medical equipment iso japanese government enacts biennial revision quality management system standard government reimbursement drug medical treatment however conceivable quality medical equipment covered national health product could questioned complication occur insurance scheme addition intense competition use product addition even case innovation technology japan overseas medical accident clearly could direct could serve greatly lower price adversely affect result company product taking preventive company operating result financial position measure countermeasure mitigate possible occurrence risk product future raw material price fluctuation occurrence could lead decrease sale rise many raw material terumo u product cost could affect company operating result manufacture plastic material derived financial position petrochemical steep rise price resource worldwide could increase price raw material legal proceeding adversely affect company operating result terumo face risk involved lawsuit dispute financial position type legal proceeding japan overseas company strives minimize legal risk exchange rate fluctuation measure continuous research effort terumos headquarters located japan part legal intellectual property financial account overseas subsidiary converted department system internal check report local currency japanese yen preparation risk management structure provided board consolidated financial statement purpose director audit supervisory board needed exchange rate fluctuation therefore influence however company sued third party conversion account yen result either damage injunction sale major gain loss company legal action taken could affect company coping fluctuation structural operating result financial position method transferring production overseas factory importing raw material along risk utilization contract hedge exchange rate factor could impact terumos operating result volatility trade receivables financial position include change trade practice however possible unexpected exchange rate terrorism war natural disaster epidemic fluctuation could impact company operating result worldwide spread new strain influenza financial position terumo corporation annual report consolidated financial statement consolidated balance sheet terumo corporation consolidated subsidiary fiscal fiscal million yen million yen fy fy fy fy asset march march liability net asset march march current asset current liability shortterm debt cash deposit current portion longterm debt note account current portion bond receivabletrade payable less allowance doubtful note account payable trade account lease obligation note account receivabletrade net income tax payable accrued expense inventory asset retirement obligation deferred tax asset current liability total current liability current asset total current asset noncurrent liability bond payable longterm debt property plant equipment lease obligation land provision retirement benefit retirement benefit liability building structure provision director machinery equipment retirement benefit asset retirement obligation vehicle deferred tax liability lease asset noncurrent liability construction progress total noncurrent liability equipment furniture total liability net asset capital stock less accumulated depreciation authorized share fy fy net property plant issued share equipment fy fy capital surplus investment asset retained earnings less treasury stock cost investment security including investment total shareholder equity security unconsolidated valuation difference availableforsale security subsidiary affiliate deferred gain loss goodwill hedge customer relationship foreign currency translation adjustment deferred tax asset accumulated adjustment retirement benefit retirement benefit asset total accumulated comprehensive income asset stock subscription right total investment minority interest asset total net asset total asset total liability net asset terumo corporation annual report consolidated statement income terumo corporation consolidated subsidiary fiscal fiscal million yen fy fy ended march ended march net sale cost sale gross profit selling general administrative expense operating income income expense interest dividend income royalty income foreign exchange gain equity earnings affiliate gain sale property plant equipment gain transfer business settlement income subsidy income interest expense loss disposal inventory loss disposal property plant equipment impairment loss director retirement benefit loss liquidation business loss information system failure loss valuation golf club membership environmental expense net income income tax minority interest income tax current deferred income minority interest minority interest income net income yen net income per common stock basic diluted terumo corporation executed twoforone stock split common share effective april net income per common stock adjusted retrospectively reflect effect stock split cash dividend per common stock terumo corporation annual report consolidated financial statement consolidated statement comprehensive income terumo corporation consolidated subsidiary fiscal fiscal million yen fy fy march march income minority interest comprehensive income valuation difference availableforsale security deferred gain loss hedge foreign currency translation adjustment share comprehensive income associate accounted using equity method total comprehensive income comprehensive income attributable shareholder terumo corporation minority interest consolidated statement change net asset terumo corporation consolidated subsidiary fiscal fiscal thousand million yen shareholder equity accumulated comprehensive income valuation number difference deferred foreign accumulated stock share capital capital retained treasury gain currency adjustment minority loss translation retirement subscription total capital stock surplus earnings stock available interest right stock forsale hedge adjustment benefit security balance march dividend surplus net income purchase treasury stock net change item shareholder equity balance march dividend surplus net income purchase treasury stock net change item shareholder equity balance march terumo corporation annual report consolidated statement cash flow terumo corporation consolidated subsidiary fiscal fiscal million yen fy ended march fy ended march net cash provided used operating activity income income tax minority interest depreciation amortization impairment loss amortization goodwill equity earnings affiliate increase decrease provision retirement benefit decrease increase retirement benefit asset increase decrease retirement benefit liability increase decrease provision director retirement benefit increase decrease allowance doubtful account increase decrease provision director bonus interest dividend income interest expense foreign exchange gain gain transfer business settlement income gain sale property plant equipment loss disposal property plant equipment payment cash contribution retirement benefit trust director retirement benefit loss liquidation business loss information system failure loss valuation golf club membership subsidy income environmental expense decrease increase note account receivabletrade decrease increase inventory increase decrease note account payabletrade net subtotal interest dividend income received interest expense paid income tax paid settlement received payment director retirement benefit payment information system failure payment environmental expense subsidy received net cash provided operating activity net cash provided used investing activity payment time deposit proceeds withdrawal time deposit purchase property plant equipment proceeds sale property plant equipment purchase intangible asset payment settlement asset retirement obligation purchase investment security payment acquisition business purchase investment subsidiary resulting change scope consolidation purchase stock subsidiary proceeds transfer business net net cash used investing activity net cash provided used financing activity proceeds shortterm debt repayment shortterm debt repayment longterm debt net increase decrease shortterm debt proceeds longterm debt repayment finance lease obligation purchase treasury stock cash dividend paid net cash used financing activity effect exchange rate change cash cash equivalent net increase cash cash equivalent cash cash equivalent beginning year cash cash equivalent end year terumo corporation annual report corporate governance corporate governance policy compliance terumo corporation annual report corporate governance policy basic stance accordance corporate mission contributing society healthcare terumo corporation responds expectation customer shareholder associate business partner community large stakeholder worldwide providing valuable product service achieve sustainable growth maximize corporate value long term terumo set forth corporate mission five statement open management enhanced value safety reliability respect associate corporate citizenship statement govern action decision made terumo associate backed corporate mission five statement terumo promotes creation framework honest effective corporate governance together commitment full accountability action terumo strives continuously earn understanding trust within outside company terumo belief corporate culture create highly motivating challenging workplace open candid communication forward looking spirit essential effective corporate governance strives diligently foster culture kind terumo employee called associate emphasize partnership collaborative working corporate governance structure governance terumo based company board company auditor system defined japan company act business activity supervised board director audit supervisory board entrusted auditing function established corporate governance committee internal control committee enhance objectivity transparency management decisionmaking strengthen oversight business activity dedicated staff assigned support audit function strengthen governance way well believe step continuously increase corporate value maintain highly transparent governance system operation terumo corporation annual report based corporate governance policy established board director board may director may independent director audit supervisory board may five member least half must external member independent director external audit supervisory board member must meet tokyo stock exchange requirement concerning independent director external auditor independent directorauditor notification appointment submitted tokyo stock exchange independent director external member audit supervisory board except one notification submitted accordance rule firm serf corporate governance structure board director board director presently consists member three independent director two director one internal one independent woman one internal outside japan elected th annual general meeting shareholder convened june addition legally prescribed body detailed company established body described view enhancing corporate governance terumo corporation annual report director board director role board director decides matter authorized relevant law regulation article incorporation internal rule monitor performance duty individual director executive officer strives optimal management decisionmaking view maximizing corporate value fulfills corporate governance function composition board director consists director may independent director independent director must satisfy criterion serve independent directorsauditors defined tokyo stock exchange board director chaired chairman representative director terumo term office director term office director one year reappointment possible corporate governance committee internal control committee company also established corporate governance committee internal control committee body serve enhance transparency objectivity management half member corporate governance committee independent director independent director chair committee corporate governance committee advisory body deliberates advises selection candidate director audit supervisory board member executive officer remuneration system audit supervisory board member executive officer internal control committee work enhance corporate governance promoting risk management compliance regard management administering timely appropriate disclosure corporate information terumo corporation annual report corporate governance committee role deliberates advises following matter order heighten fairness board director management transparency corporate governance structure enhancement selection candidate position director audit supervisory board member executive officer establishment remuneration system director audit supervisory board member executive officer composition comprised maximum six member drawn independent director representative director individual named committee chair half membership must independent director satisfy criterion serving independent directorsauditors defined tokyo stock exchange committee chair chair corporate governance committee selected among independent director mutual vote committee member internal control committee role promotes risk management compliance respect management administers legally mandated timely disclosure corporate information composition comprised director appointed committee chair general manager relevant division well head specialized group internal audit department internal control department audit supervisory board member attend internal control committee meeting committee chair internal control committee chaired president representative director company terumo corporation annual report audit supervisory board audit supervisory board comprised four member two external member determines governance practice place practice place work ensure propriety daily management activity including board director function audit supervisory board member monitor performance duty director example attending board director executive management important meeting may state fair impartial opinion management generally particular matter enhance audit function audit supervisory board office established staffed fulltime personnel support organization audit supervisory board member audit supervisory board member hold monthly report meeting internal audit department receive report internal audit financial reporting internal control undertake activity aimed ensuring strong relationship internal audit department audit supervisory board member also attend internal control committee meeting receive regular report establishment implementation evaluation internal control regarding cooperation independent auditor audit supervisory board member meet approximately six time annually independent auditor actively sharing view information receive report ongoing audit needed audit supervisory board member also perform activity receiving report needed financial reporting internal control ensure system enabling performance fair audit place audit supervisory board member audit supervisory board role audit supervisory board member audit supervisory board audit supervisory board member attend meeting board director important meeting audit execution duty director offer pointed input regarding management required audit supervisory board responsible following preparation audit report election dismissal fulltime audit supervisory board member determining audit policy method assessing status company operation financial asset matter pertaining duty performed audit supervisory board member terumo corporation annual report composition consists five audit supervisory board member half must external audit supervisory board member external audit supervisory board member must meet term stipulated japan company act satisfy criterion serve independent directorsauditors defined tokyo stock exchange chair audit supervisory board elected resolution among audit supervisory board member term office term office audit supervisory board member four year reappointment possible internal control accordance japan company act terumo corporation board director approved internal control system basic policy given internal control committee take lead promoting establishment internal control system within terumo group internal control system basic policy system ensuring execution duty director employee consistent relevant law ordinance article incorporation ① step taken ensure thorough compliance code conduct terumo group confirm every director employee group understands code conduct terumo group addition education enlightenment activity conducted ongoing basis foster sense ethic enhance compliance awareness among employee ② internal control committee deliberates compliance important matter report result regular basis board director ③ internal audit department audit group status regard compliance regularly report result representative director audit supervisory board ④ use internal whistleblowing system promoted uncover activity legally questionable system retaining managing information performance duty director ① accordance documentation management standard information performance duty director recorded paper electronic form referred documentation retained ② system maintained allows director audit supervisory board member view terumo corporation annual report document time rule systematic approach management risk ① regarding individual quality compliance disaster environmental information security type individual risk expert unit risk category educate guide employee ongoing basis accordance relevant rule provision ② internal control committee deliberates important risk management matter work expert unit compliance officer group company establish risk management system span breadth optimal terumo group internal control department work advance system system ensuring efficiency performance duty director executive management committee company committee market product strategy committee committee consisting director executive officer others member make decision toward achievement mediumterm management annual plan approved board director enhance terumo group corporate value promote shareholder common interest promote efficiency speed expert committee provide support guidance oversight business unit system ensuring proper operation corporate group consisting company parent company subsidiary ① regarding terumo group internal control committee working close cooperation head terumo corporation unit compliance officer group company reinforce system swift efficient communication instruction report relating propriety group operation internal control department work advance action taken internal control committee ② internal audit department conduct internal audit group regularly report result representative director audit supervisory board matter related employee assigned assist audit supervisory board member performance duty independence assigned employee director audit supervisory board office dedicated staff support performance audit work audit supervisory board member evaluation transfer staff require consent audit supervisory board system reporting audit supervisory board member director employee system reporting audit supervisory board member ① director employee may submit report audit supervisory board member necessary based legal provision separately provided internal rule governing reporting matter director employee audit supervisory board member ② deemed necessary audit supervisory board member audit supervisory board member may receive report needed director employee terumo corporation annual report system ensuring auditing audit supervisory board member conducted effectively ① audit supervisory board representative director regularly hold meeting share opinion ② audit supervisory board member may attend executive management important meeting ③ audit supervisory board hold monthly meeting internal audit department meet regularly independent auditor meet internal audit department independent auditor time necessary executive compensation compensation director independent director consists fixed portion bonus stock option compensation independent director audit supervisory board member consists fixed amount process determining compensation described table compensation director audit supervisory board member related matter disclosed within asset security report business report posted terumo corporation website process determining compensation director audit supervisory board member category determination process fixed within compensation limit approved th annual general meeting shareholder compensation director compensation decided resolution board director audit supervisory board member compensation decided audit supervisory board meeting bonus light factor year business result business environment bonus amount proposed annual general meeting shareholder submitted board director approval stock option decision stock option made board director resolution within compensation limit mentioned standard payment fixed compensation excluding audit supervisory board member bonus stock option considered corporate governance committee light information including provided outside research organization comparable standard used company terumo corporation annual report timely disclosure information terumo aim company trusted throughout society emphasizing transparency fairness continuity make information disclosure shareholder investor customer stakeholder required financial instrument exchange act tokyo stock exchange timely disclosure rule also engage timely proactive disclosure information believe effective enhancing understanding company system timely disclosure line corporate governance policy established disclosure subcommittee determine proposed disclosure handled positioned internal control committee disclosure committee make decision based consideration necessity disclosure timing matter legality propriety concerning documentation proposed disclosure disclosure subcommittee subcommittee structure disclosure subcommittee composed head public relation corporate planning secretarial internal control department head public relation department chair subcommittee convenes meeting necessary chair determines necessary people subcommittee member may also asked attend public relation department act administrative section subcommittee performing disclosure procedure taking archiving meeting minute subcommittee role disclosure procedure head unit responsible management subsidiary together referred responsible manager information resulted business activity could become subject disclosure agenda item board director executive management meeting internal control committee together referred committee scheduled meet information submitted disclosure subcommittee disclosure subcommittee considers necessity disclosure timing matter legality propriety concerning information proposed disclosure instructs responsible manager subcommittee administrative section necessary action committee scheduled meet deliberates agenda render final decision disclosure terumo corporation annual report compliance compliance system terumos corporate mission contributing society healthcare goal company associate work terumo continue conduct honest fair business practice based strict legal compliance corporate ethic order maintain position ethical healthcare company promote honest fair business practice terumos board director approved basic policy internal control system accordance basic policy established internal control committee deliberates executes important groupwide compliance issue addition based direction internal control committee group company appointed compliance officer whose role facilitate carry compliance activity company activity internal control committee receives discusses important information enhance groupwide compliance activity compliance code conduct terumo group go toward meeting social expectation established code conduct terumo group april set standard conduct daily business activity entire group including overseas entity accordance code striving throughout terumo group base action social ethic well compliance relevant law regulation code conduct terumo group based terumos corporate mission heart terumo state associate must conduct business activity honestly take responsible action environmental conservation make consistent effort enable company become model reliable corporate citizen carry training code conduct tailored site encourage associate recognize importance corporate ethic global company also clearly state promote need respect human right eliminate discrimination code conduct terumo corporation annual report appropriate relationship public official terumo associate observe code conduct terumo group terumo group global antibribery policy established may dealing public institution related official employee public medical institution code aim ensure business conducted fair transparent sound honest manner full compliance expected japan unfair competition prevention act u foreign corrupt practice act antibribery law within country region terumo group operates combatting antisocial force avoiding relationship antisocial force one terumos corporate responsibility therefore strictly refuse become involved relationship antisocial force engage transaction company organization individual tie antisocial force furthermore work law enforcement authority agency combat antisocial force status effort combat antisocial force general affair department coordinate response inappropriate demand antisocial force prevention inappropriate demand made specific responsibility designated associate within general affair department established system cooperating law enforcement authority tokubouren npo assisting company combatting corporate blackmailer legal adviser others acting advice guidance established system properly receiving information antisocial force tokubouren source centrally managing general affair department prepared manual combatting antisocial force promoting thorough understanding content among everyone working terumo provide executive associate relevant information timely manner conduct training take ther step well promote awareness importance combatting antisocial force terumo corporation annual report corporate ethic hotline established corporate ethic hotline internal whistleblowing system corporate ethic hotline enables associate report consult matter situation believe inappropriate light code conduct terumo group system enables associate regardless employment status contact hotline phone email written letter anonymous basis time maintain outside point contact office corporate attorney way whistleblower assured privacy protection retaliation promote hotlines usage address reported issue corporate ethic hotline work terumo corporation annual report abiding industry rule terumo abides code practice promotion code fair competition code industrybased rule ensure follows appropriate promotion practice medical device pharmaceutical effort fulfill social responsibility engage ethical business activity also established terumo code practice compliance industry internal rule remain top priority going forward terumo corporation annual report intellectual property global rd system utilization intellectual property business segment patent measure counterfeit product global production system quality management factory terumo corporation annual report global rd system present global medical device market undergoing seismic shift aging japan society continues industrialization healthcare nursing care led flood new entrant different business sector hand emerging country seeing rapid growth medical device market development healthcare infrastructure progress step economic advancement moreover western country demanding medical device product system offering even higher medical cost efficiency given curtailment medical expense key priority market landscape becomes increasingly complex way terumo working develop introduce new product according regional market need aim growing enterprise strong presence global stage terumo group rd base terumo corporation annual report boosting development since terumo actively acquiring company technology establishing subsidiary worldwide basis obtaining technology strengthening product line capturing market share important objective undertaking activity another key interest however creation synergy combining fundamental technology long strength company give rise new value technological innovation fiscal year ended march example acquired usbased harvest technology corporation company outstanding technological capability cuttingedge medicine notably device harvesting various cell used stimulate surgical wound healing used cellular therapy january acquired technology usbased onset medical corporation adding unique large internal diameter sheath product line solidified terumos leading position area vascular access management enhancing development capability terumo corporation annual report realize synergy overseas subsidiary terumo recent year actively assigned engineer japan foreign subsidiary encourage codevelopment local engineer moreover order respond healthcare regulation country group company collaborate one another pta balloon catheter headquarters function terumo business division placed overseas mean terumo created structure enables faster global promotion new product also collaborating actively company april instance signed agreement kaneka corporation expand peripheralinterventional business codevelopment pta percutaneous transluminal angioplasty balloon catheter use treating peripheral lower extremity artery disease march entered agreement arterial remodeling technology sa art france acquire exclusive acquisition right company developing bioresorbable stent technology agreement also pursue joint development drugeluting bioresorbable stent make staged investment art actively collaborating company invest development activity expanding market serve beyond existing field business new rd system based globalized businessled management anticipating impending shift companyled global management approach april reorganized rd two group july one company rd group charge developing product pipeline consistent business strategy nine business responsible integrated management everything product development production sale particular area based management strategy three company group corporate rd led rd headquarters corporate rd pursues rd aimed terumo corporation annual report coming nextgeneration product existing business creating new business existing company also performs function developing terumos competitively superior basic technology performs evaluation function acquiring efficacy safety data required submitting regulatory application strengthen terumos overall rd capability corporate rd engages human resource development work create new development approach new rd system based globalized businessled management terumo corporation annual report rd headquartersgiving rise innovation corporate rds mission create new value accurately assessing need medical setting advance new development activity focused early commercialization created development system spanning everything early stage development commercialization along two axesinternal development external development activitiesand conduct broad search effort create future product portfolio internal development advance new search activity specified field employing project team member including engineer also associate broad range function outside expert strives speedy commercialization clear target process new development external development activity take place global basis silicon valley prime example october committed invest emergent medical partner ⅱ emp ii venture capital fund managed dr thomas fogarty prominent cardiac surgeon inventor key aim investment gain early access technology developed highly promising venture business time established terumo medical innovation inc transferred fogarty institute innovation incubator operated dr fogarty inhouse development aim achieve clearly defined product objective speedy commercialization pursuing discovery defined area need search medical setting project team composed engineer also associate outside expert across wide range functional ax terumo corporation annual report emergent medical partner dr thomas j fogarty right empⅱ office silicon fii ceo ann fyfe valley upgrading improving sharing fundamental technology technology increase biocompatibility one example essential technology commonly required development manufacture medical device kind biocompatibility technology improved daily basis shared throughout terumo group medical device used diagnostic treatment purpose accessing patient body many different way medical device make contact surface patient body others inserted within body implanted body extended period time reason key priority access patient body safely minimizing undesirable physical burden patient enhancing biocompatibility product developing material inhibit allergic reaction blood clotting response making structural enhancement one factor distinguishes product outstanding medical device furthermore material used medical device must offer various characteristic light resistance deformity resistance sterilization resistance pharmacological compatibility according application terumos wealth experience technology material field put good use entire process development selection appropriate material processing forming shape reflect userfriendliness consideration performance processing molding sterilization production operation material terumo applies efficient rigorous quality assurance system based technology expertise production technology underpinned many year proven experience addition terumo factory amasses production technology related product manufacture taking part crossfactory system assist production factory ensures highquality production system factory terumo corporation annual report organizational capability link translating technology product medical device represent integration extremely diverse range elemental technology host scientific discipline including physiology biochemistry pharmacology cell technology polymer technology metal processing technology electronics use within human body regulatory authority japan elsewhere set bar safety exceptionally high approving manufacture sale device discussed earlier terumo group variety elemental technology bulk human resource possess highly sophisticated expertise however stay ahead basic flow chart development sale medical device industry made fiercely competitive new entrant outside industry deliver new product society rapid steady pace company must organization framework capable integrating existing inhouse elemental technology concrete product development controlling flow linking product sale dealing rigorous approval process specific medical device achieve terumos rd headquarters strengthening project management function expediting research commercialization twopronged structure consists group responsible seeking new medical need underdeveloped technology draw new value charged developing product mass production base underpinning structure located rd center key terumo factory configuration establishes environment entire process initial rd stage new product mass production stage occur unimpeded part structure terumos evaluation center capacity evaluate device along physical chemical biological dimension evaluation center gather experimental terumo corporation annual report data rd headquarters factory need rd activity enabling nonclinical study precede clinical trial performed inhouse capacity added merit enabling terumo acquire expertise performing safety evaluation responding diverse range technology addition numerous department functionally interlinked early stage development allowing efficient conversion rd activity viable product department include coordinate clinical trial responsible submitting application compliance foreign domestic regulatory affair law negotiating approval body research oversee postmarket product effectiveness safety matter intellectual property department charged research protection intellectual property right recent year terumo promoted strategic collaboration overseas subsidiary leveraging competitive edge multiple development base overseas swiftly incorporate technology develop new product example terumo conducted clinical trial based european union regulation trial implemented speedily japan also performed simultaneous multinational clinical trial close collaboration subsidiary trial aimed obtaining early approval enabling approval body country share data obtained respective country terumo honed organizational frameworkone smoothly support process product development salesin course business activity long history medical device company result initiative proactive business alliance leading company around world recent year framework make vital part intellectual asset support terumos strength terumo corporation annual report utilization intellectual property business segment basic policy terumo currently operates three core business segment exploring new field expected drive future business development business segment unique characteristic based difference product intended user attribute accordingly terumo plan promotes optimal business development initiative business segment combining proper material production technology regulatory affair strategy product management company comprised two componentsadvanced product platform product advanced product innovative highgrowthhighmargin shortlife cycle platform product stablegrowthhighmargin longlifecycle product offering upgraded improved performance managing product stable earnings platform product invested advanced product brand image technology advanced product feed back platform product cardiac vascular company cardiac vascular company good example business terumo combine two elemental technologiescoating metal alloymetal processing technology example incorporated superelastic metal alloy technology intravascular imaging guide wire laser processing technology ptca percutaneous transluminal coronary angioplasty balloon catheter addition application hydrophilic coating coat product play key role achieving improved accessibility deep blood vessel recent year terumo developed introduced stent combining precision processing microfabrication technology elemental technology stent feature highly flexible design ensure resistance compression bending twisting normal body movement present terumos longterm goal become company global presence realize goal applying technology nurtured cardiac vascular field enhance product pipeline medical imaging peripheral intervention neuroendovascular intervention group elemental technology precision processing miniaturization technology also put good use terumo corporation annual report employed proprietary zigzag cell link structure made nickeltitanium alloy give outstanding flexibility durability misago stent used treating peripheral blood vessel misago stent treating peripheral blood vessel attendant delta occlusion micro balloon catheter used temporarily blocking blood vessel enable access even fine labyrinthine peripheral artery employing design external diameter less mm proven hydrophilic coating attendant delta occlusion micro balloon catheter use hydrophilic coating scepter c cerebrovascular occlusion balloon applying surface balloon portion well better access peripheral artery wind complicated way scepter c cerebrovascular occlusion balloon give hiryu plus ptca dilation catheter durability flexibility conform shape blood vessel employ threelayer structure combining pliable material balloon another highly durable material hiryu plus ptca dilatation catheter terumo corporation annual report new product ultimaster drugeluting coronary artery stent design goal reduce stress blood vessel improve disease prevention enabled use cobalt chromium alloy unique stent design improve ability navigate convoluted blood vessel facilitate stent placement conformance vessel curvature ultimaster drugeluting coronary artery stent redesigned balloon attendant nexus occlusion micro balloon catheter give capsule shape variable expansion control expanded right amount necessary occlude target vessel placed greater ease attendant nexus occlusion micro balloon catheter general hospital company general hospital company terumo provides medical device system used treatment hospital bedside home terumo adopting technology responsive different way medical device used offer value added medical device leveraging strength pharmaceutical technology medical device designed safety ease use care provider mind medical device specifically home health management preventive medicine surflo v iv catheter launched one example responsive approach technology adoption lower risk hospitalacquired infection surflo v employ proprietary design feature aimed reducing risk inadvertent needle stick preventing blood spatter feature improve safety also ease use medical personnel surflo v iv catheter terumo corporation annual report top manufacturer needle wealth technology developed many year apply technology improve patient quality life product meet need uncovered taking user perspective one product nanopass pen needle insulin injection available globally needle thin design unsurpassed world based terumo research nanopass insulin injection august uniquely shaped tip ease pain injecting needle insulin addition combining insulininjection needle technology technology developed many year plastic prefilled syrinx used japan moving forward development highvalueadded prefillable drug agent plastic syrinx overseas pharmaceutical company aiming establish unique business model area plastic prefilled syrinx also working develop highvalue prefillable syringe added product compatible drug considered pharmaceutical company fill difficult offer prefilled syrinx include therapeutic market finished product agent biomedicine drug high demand frontlines medicine another high priority development theme bringing together collection vital data electronic medical recordkeeping range new device aimed reducing administrative burden nursing staff developed thermometer blood pressure blood glucose measurement device use onboard data communication capability automatically enter vital data patient record device free nursing staff turn attention important task negate problem data entry omission mistake delay hr joint series measuring device system communication function terumo corporation annual report blood management company terumos blood management product centered blood bag used country region around world blood collection method formulation method collected blood sample differ country region terumo teamed optimal partner company region develop supply product ideal local market developed country example blood transfusion therapy recent year come dominated use blood component preparation rather whole blood donor order efficiently separate blood component patient require whole blood terumo andreas hettich gmbh co kg hettich wellestablished german manufacturer centrifuge equipment clinical laboratory usage jointly tacsi automated blood component developed automated blood component processing system processing system tacsi combining terumos proprietary blood bag technology hettichs centrifuge equipment system automates process extracting necessary component blood raw material result system improved precision entire blood component production process dramatically increased work efficiency contributing safety advancement blood transfusion homogenization enhanced quality blood component preparation apheresis therapy blood plasma exchange gathered attention recent year new treatment alternative patient autoimmune inflammatory viral intractable disease cause yet identified terumo develops supply equipment removing patient plasma including pathogenic substance replacing donated plasma used apheresis therapy spectrum optia therapeutic apheresis treating intractable disease system following consolidation terumo group blood management business terumo bct looking ahead spurring advancement plateletpheresis cell therapyrelated technology former caridianbct terumo pursuing rd grow business one deliver greater added value terumo corporation annual report new field terumo hard work pursing opportunity regenerative medicinea new field promising future growthwhile also striving achieve nextgeneration development build new business traditional field endeavor based corporate mission contribute society healthcare developing new application minimally invasive treatment device new drug delivery device new product focused reducing pain improving postoperative care regenerative medicine terumo embarked research cardiac regenerative medicine year ago technology developed patient cell harvested cultured cell sheet produced applied patient heart present engaged world first therapeutic use cell sheet treatment performed japan view toward commercialization drug delivery device meanwhile area drug delivery device developed device make intradermal injection possible adding traditional intravenous subcutaneous intramuscular pathway drug delivery intradermal delivery known enhance sensitizing potential vaccine therefore expected increase number patient benefit small amount precious vaccine new device brings simplicity reliability intradermal injection hoping lead major innovation daiichi sankyo company limited reached basic agreement april apply respective expertise field pharmaceutical medical device commercialize new infectious disease vaccine moving ahead clinical development pain management adhesion postoperative qol quality life improvement initiative terumo pursuing development make medical treatment kinder gentler field surgery well acelio intravenous injection mg intravenous injectable acetaminophen antipyretic analgesic aid management cancerrelated postoperative pain went market november looking expand line pain management product take step add effort help improve patient comfort surgical adhesion another qol issue patient working prevent altogether surgery internal organ become firmly attached surgery site adhesion known occur great frequency regardless type surgery cause complication bowel obstruction chronic pain infertility prevent adhesion developed adhesion barrier form sprayon gel currently undergoing clinical study japan minimally invasive treatment device terumo first time ever taken challenge terumo corporation annual report developing therapeutic device field urology work performed venture company established silicon valley one world prominent location startup working bring new medical device market another front also developing minimally invasive treatment device help growing number people suffering disease lower extremity fulfill terumos mission contribute society healthcare going beyond traditional area business develop product deliver new value based thorough understanding need medical setting company core intellectual property unique operation freely apply one company endeavor another ongoing effort develop innovative sheet skeletal myoblasts product skill terumo corporation annual report patent fundamental policy strategic positioning terumo belief management innovative idea patent form intellectual property activity strategically use intellectual property convert profit critical manufacturer terumo group established following two fundamental policy global intellectual property development activity foster culture innovation increase stock intellectual property terumo group formulates promotes global intellectual property strategy closely coordinated rd business strategy ensures innovative idea generated global rd activity including overseas site provide base intellectual property contributes profit terumo group global business operation conducting ip development activity across divisional boundary terumo engineer intellectual property staff work closely together initial stage development invention creation new technology pursued based comparison terumo invention patent product competitor consideration direction taken development activity type intellectual property portfolio built terumo created environment intellectual property staff casually consult engineer promote efficient intellectual property development activity terumos intellectual property department work strengthen patent application activity intellectual property right country region enhanced intellectual property portfolio necessary contributing growth terumo group invention terumo corporation annual report fostering awareness intellectual property terumo belief raising associate awareness intellectual property stimulating interest topic vital enlarging valuable intellectual property portfolio based belief terumo internally disseminates news intellectual property right various country around world timely manner every year terumo also conduct wide range training program organized intellectual property department program structured systematically according associate level job category ranging basic course specialized practical skill training training program part effort create condition enable endless creation invention technical idea patent portfolio number patent filing recent year terumo selecting number patent filing patent application filing strategychoosing make initial patent application filing japan filing via direct pct application filing u exampledepending specific invention graph show number initial patent application filed terumo past several fiscal year initial filing fiscal year terumo making initial patent application filing per fiscal year past terumo corporation annual report number patent filing fiscal year ended march business segment today terumo file roughly many patent number patent filing fy around new theme unconnected current business segment operation patent direct bearing general hospital cardiac vascular company illustrates terumo committed improvement existing product also investing actively effort drive future business expansion enter new area number patent held region present terumo hold around patent number patent held region worldwide patent key medical device market japan u europe account figure terumo expecting increase number patent hold china emerging market going forward terumo corporation annual report measure counterfeit product foregoing activity make clear terumo must constantly safeguard strengthen brand image expands business globally counterfeit product tarnish terumo brand could negatively impact user trust manufacturer terumo obligation take resolute measure clamp counterfeit product includes identifying product early stage global survey one survey terumo determined u company selling radial artery hemostasis device made china called rband terumo belief product infringes patent trademark associated trband product accordingly brought lawsuit u company new jersey federal court february terumo corporation annual report global production system recent year terumo pushing ahead globalization production japanese factory serving principal manufacturing facility actively propagating transferring control production technology develop overseas production center mainly asia provide support enable stable production requisite performance quality overseas facility back japan long working create multipolar production configuration established new factory yamaguchi prefecture new construction also planned overseas production new building added existing plant site vietnam increase production interventinal product philippine increase production syrinx needle furthermore second whole new plant built vietnam meet growing demand transfusion product demand also rising coil used treat cerebral aneurysm new factory opened costa rica respond need building global production system key facility japan part asia giving ability meet global demand simultaneously enhancing cost competitiveness strengthening global production system terumo corporation annual report new japanese facility support global production system terumo yamaguchi corp terumo group new yamaguchi factory terumo yamaguchi corp located within squaremeter yamaguchi techno park began operating april medical device separation development work production impossible highly advanced highprecision production technology suited transfer overseas terumo positioned production site japan mother factory developing core product technology refining others new yamaguchi factory expected play key role manufacturing catheter dd drug device product requiring use advanced production technology yamaguchi chosen location factory two basic reason one need prepare disaster geographically dispersing production facility concentrated eastern japan reason location yamaguchi city presented attractive benefit term convenient access stable supply electric power outstanding human resource present factory engaged test production catheter guidewires related technology expertise transferred factory japan work proceeding apace transition commercial production coming fiscal year also plan begin production dd product terumo corporation annual report quality management factory quality assurance system meet international standard since established quality management system response european medical device directive blended globalstandard system advanced quality assurance system based existing pharmaceutical gmp good manufacturing practice standard stepping effort develop quality management system robust enough meet everstricter global requirement strict quality control factory terumo obtained certification iso international quality standard medical device equipment production site outside japan also keep date development regarding japan pharmaceutical affair act regulatory trend requirement medical device pharmaceutical product outside japan including eu medical device directive u fda regulation strengthened recent year emerging country regulation tightening response accelerating global harmonization strive continually improve quality management system anticipation new trend requirement pharmaceutical gmp pharmaceutical manufacturing guideline issued regulatory authority ensure product safety quality throughout phase receipt material manufacturing shipment product iso iso standard assure quality medical device equipment terumo quality policy top management set quality policy develop operate quality management system maintain effectiveness division also set quality objective based quality policy way policy devised top management incorporated individual associate objective customer perspective appears top quality policy basis quality assurance terumo corporation annual report quality policy order deliver safety reliability healthcare field shall pursue product valuable customer understand role quality system practice always review improve way business terumo corporation respect bioethics developing evaluating medical device pharmaceutical terumos first concern dignity life pursue business activity comply relevant law ordinance follow social norm give equal weight science ethic outlined company rule regarding use animal rd product evaluation head animal experimentation group established animal experimentation committee enabling u supplement r principle clearly specified revision japanese law fourth r standing responsibility animal experimentation committee undertakes employee education initiative examines experimentation plan confirms experiment properly carried finished performs inspection determine whether animal properly cared ensure responsibility use animal experimentation assured evaluation performed japan health science foundation organizational approach animal testing compliance basic guideline animal experimentation organization jurisdiction japanese ministry health labour welfare r principle first proposed w russel r l burch three rsreplacement switching research approach use animal reduction use fewer animal refinement reduction pain felt animal principle ethical use animal experimentation japan rs codified revision act welfare management animal terumo corporation annual report auditing system maintain high quality maintain improve quality implement internal audit objectively evaluate whether quality management system appropriately implemented followed audit conducted associate trained within company perform internal audit result reported top management direct improvement basis continually upgrade quality management system terumo also complies addition undergo several external audit year verify increasingly strict external audit compliance japan pharmaceutical affair act u regulation europe country requirement corporate customer strict quality control facility outside japan role played factory outside japan increase importance provide associate outside japan expertise cultivated japan improving quality turn learn much perspective systematic approach standardization exchange increase factory outside japan also begun introducing shoki ryudo initial quality assessment evaluation method developed japan initial quality assessment system designed reaffirm quality product specification new product customer perspective shifting mass production terumo corporation annual report stakeholder together customer value communication customer providing information ensure appropriate use listening customer reflecting customer feedback product making relationship corporate activity medical institution transparent together shareholder investor together partner together associate employment motivation providing safe workplace promoting diversity human resource development worklife balance social contribution activity closeup better therapeutic technique healthcare professional throughout world terumo corporation annual report value communication customer believe terumos role responsibility support healthcare providing safe high quality product service maintaining open honest communication customer part responsibility terumos relationship customer terumos customer include healthcare professional patient general consumer concerned health terumo believe role accurately understand customer need develop product real value place equal importance providing information support ensure customer use product peace mind direct close communication customer carry business activity way contributes healthy living product development service relationship customer chart terumo corporation annual report providing information ensure appropriate use believe terumos role responsibility support healthcare providing safe high quality product service maintaining open honest communication customer part responsibility ensuring appropriate use medical device pharmaceutical product terumo mr gather swiftly provide accurate information medical institution ensure appropriate effective safe use medical device pharmaceutical product terumo medical pranex comprehensive center technical training medical professional terumo offer range supporting medical training support training area interventional treatment terumo medical pranex injection taking blood sample mr stand medical representative terumo associate provide information medical institution supporting training medical institution help prevent accident usage syrinx transfusion set medical device terumo conduct tpas training medical institution tpas emphasizes key point using individual device enables medical professional learn handson training scenario participant feedback indicates tpas training provides tangible sense situation lead accident demonstrates support training correct understanding use device must based something usage medical device assumption casual advice others showing value program conference quality safety practice medicine benefit tpas training often reported hospital throughout japan terumo corporation annual report listening customer believe terumos role responsibility support healthcare providing safe high quality product service maintaining open honest communication customer part responsibility terumo call center terumo call center japan receives call per year general consumer medical institution distributor ensure inquiry related respective class productsfrom designed medical institution home medical careare addressed promptly appropriately call center staff respond expertise field call center staff committed maintaining improving inquiry addressed staff satisfaction caller ensuring urgent inquiry specialized knowledge related patient receiving healthcare home responded hour center also enhancing ability internally reflect customer feedback improvement development product terumo corporation annual report reflecting customer feedback product believe terumos role responsibility support healthcare providing safe high quality product service maintaining open honest communication customer part responsibility medical safety information management japan accumulate information customer quality safety appropriate use product postmarket surveillance vigilance dept using information promptly develop refine communication delivering various way including attachment important information product web site via industry organization sending mr medical institution facetoface explanation furthermore use accumulated information develop improve product support medical safety training medical institution tpas tpas terumo proactive action safety training program based terumos predictive safety measure providing easytouse product service terumo incorporates ergonomic design many product promote safe simple operation smart infusion system terufusion infusion pump syringe pump apply data communication function greater safety ease use systembased delivery drug onboard drug library function allows setting flow limit specific drug prevent mistake use universal design font make smart infusion system terufusion syringe pump designed facilitate display easy read use medical staff universal design font letter font meticulously designed specifically ease use visibility mind terumo corporation annual report making relationship corporate activity medical institution transparent communicate terumos contribution life science high ethical standard conduct business activity formulated transparency guideline relationship corporate activity medical institution transparency guideline relationship corporate activity patient organization terumo corporation annual report together shareholder investor provide stable return shareholder improved corporate value terumo committed open management includes fair timely disclosure communication shareholder investor basic policy regarding shareholder return ensure higher profitability sustainable growth terumo actively promotes appropriate aggressive reinvestment profit work expand corporate value even believe serf interest shareholder lead increased investment value basic policy profit allocation stably increase dividend shareholder commensurate business performance targeting medium longterm dividend payout ratio basic policy regarding ir disclosure aim earn broad social trust terumo discloses information accordance timely disclosure rule set forth financial instrument exchange act tokyo stock exchange based principle transparency fairness continuity addition terumo strives provide timely proactive disclosure information may effective providing better understanding company terumo corporation annual report communicating shareholder investor general meeting shareholder annual general meeting shareholder present financial result also explain product technology contributing better healthcare video featuring commentary customer associate employee terumos effort realize corporate mission also shown prior meeting meeting venue create display section product shareholder view product exhibition general medical device equipment close way strive meeting shareholder impart deeper understanding terumo facility tour better inform shareholder year invite shareholder visit terumo medical pranex get sense training provide medical professional handle product believe help better understand make also view motivation terumo medical pranex multipurpose training facility medical professional learn use catheter advanced medical technology group physician nurse tour held shareholder strengthen ability work team result briefing result briefing held security analyst institutional investor quarterly teleconference st rd quarter company representative director key associate attend briefing explaining business result factor behind change management strategy going forward material provided briefing along individual presentation also posted website available result briefing investor terumo corporation annual report briefing event individual investor provide opportunity direct dialogue individual investor terumo hold company briefing location throughout japan also active exhibiting ir event held tokyo stock exchange others targeting individual investor event individual investor terumo corporation annual report together partner terumos corporate mission contributing society healthcare reflected procurement activity vital patient healthcare professional able use product safely peace mind therefore exercise great care selecting vetting supplier raw material service raw material procurement policy october developed human x eco development guideline line commitment people environmentfriendly company guideline making effort reach new level people environmentfriendly procurement particular consideration given following selecting material produce harmful impact next generation reducing environmental impact selecting material used effectively produce waste saving resource based idea maintain fair equitable relationship supplier time continue procure raw material compliance pharmaceutical regulation rule respective country concerned terumo corporation annual report promoting continuous quality improvement ensure product quality actively seek upgrade quality control raw material also service affect quality management system design production facility mold outsourced production particular stricter fda regulation medical device recent change made important manage quality across global supply chain fully aware quality material service provided supplier impact quality final product supply work supplier make continuous improvement quality conduct regular audit qa system also share qa audit information quality information terumo group production site effort improve quality final product better procurement activity initiative stable procurement terumo manufacture product five factory within factory outside japan distributes country rapid change procurement place top priority ensuring quality stable supply procure material appropriate source deliver high quality product healthcare provider despite supply interruption caused great east japan earthquake able keep medical supply flowing customer working supplier based shared understanding supply healthcare must come firstthat healthcare must stopped based experience sought cooperation supplier making improvement enhance safety reliability supply chain terumo corporation annual report supplier survey japan year terumo conduct survey supplier make improvement ensure become trusted purchaser supplier survey includes wide range question involving transaction terumo cover topic including business manner transactional ethic select material ensure stable procurement without interruption healthcare added survey regarding business continuity planning bcp beginning based response opinion business partner analyze issue facing material division provide feedback factory material division feedback aid resolving issue identified also serf tool verifying direction reflecting customer input procurement activity going forward necessary also meet directly partner provide opinion work improve relationship trust purchasing compliance education measure ensuring good mutual communication supplier terumo brief employee basic rule supplier including supplier selection ordering payment conduct training ensure employee familiar understand act delay payment subcontract proceeds etc subcontractor abbreviated document subcontracting law internal purchasing compliance training addition building awareness internal control also work maintain improve compliance subcontracting law addition terumo promotes encourages understanding subcontracting law actively participating workshop held fair trade commission small medium enterprise agency month government promotes compliance act run series check interview verify compliance status work thoroughly instill reaffirm understanding key point compliance terumo main subcontracting enterprise terumo corporation annual report employment motivation meaning terumo associate terumo greatly value associate important asset take pain create environment promotes development people place great importance enhancing value individual time expect associate take responsibility enhancing personal value contribute overall development terumo ultimate objective terumo associate work together improve medical care patient around world terumo employee called associate emphasize partnership collaborative working fostering motivating challenging work environment terumo respect individuality associate working foster work climate individual realize maximum potential also provide ample opportunity willingness grow widen field activity goal based initiative enable associate contribute individual strength team enhancing performance creating strong motivating workplace patient day project root motivates associate strong belief work meaningful captured corporate mission remained unchanged since founding contributing society healthcare tp day smile pleasure terumo patient day conceived opportunity associate reconnect mission consider mean personally contribute furtherment medical care reflect value provide society tp day associate listen moving account patient actually struggle overcome illness associate also opportunity visit actual place medicine practiced enables see concrete way connection terumo corporation annual report every day work frontline patient healthcare tp day project include collaboration japanese nursing association enhance associate understanding nursing work event conduct give associate chance meet talk medical professional fiscal tp day activity held terumo group tp day location throughout world tp day abbreviation smile pleasure terumo patient day activity terumo medical product hangzhou co ltd approximately associate terumo medical product hangzhou co ltd hangzhou plant largest overseas business location function critical production facility distribution center fall athletic meet carnival terumo group product enable supply family day increasingly highquality product develop people even higher skill ability undertaken various initiative aimed creating condition allow associate work vitality pride hangzhou plant spring example offsite event held associate refresh mentally physically fall organize athletic meet attended entire workforce family large stadium provides thrilling venue heated though friendly competition provides powerful way foster unity addition plant worker union frequently arranges trip organizes activity various union member club including flower arranging cooking popular among female associate plant dormitory single employee governing committee also actively terumo corporation annual report organize event activity seiri streamline seiton organize seiso clean seiketsu hygiene shitsuke selfdiscipline study group birthday party contribute making life dorm enjoyable familylike believe continually holding activity deepens relationship among associate contributes unity hangzhou plant ultimately form strong foundation terumos production sale endeavor aim deliver product safely peace mind feedback motivation survey japan help create highly motivating challenging workplace open candid communication forward looking spirit regularly conduct feedback survey executive general manager associate engagement survey also carried japan based associate result survey provides valuable insight management leadership team enabling u continually strive make terumo even better place work ace inhouse job posting system japan terumo operates inhouse job posting system called ace set system enables associate range department job type enhance career taking new challenge opportunity example management position medical device venture company terumo established u recently posted japan based associate unrelated division applied successful ace applicant selected happily working new job u introducing product trade show africa system open associate regardless age gender present opportunity gain experience develop business professional strong desire move career next level terumo corporation annual report far associate taken advantage ace system talent pool global candidate also set half already global assignment outside japan others accelerated development position within japan preparing transfer abroad fiscal total application individual passing screening process winning chance pursue new area opportunity genbano hokori award honor frontline award terumos growth supported highly visible associate achieve outstanding result also many associate consistently produce solid result work diligently behind scene every day reward recognize associate genbano hokori award literally honor frontline award presented year winner genbano hokori award fiscal fiscal award presented five associate chosen around nominated fellow associate among recipient veteran associate working distribution overseas plant since first opened associate charge transferring production knowledge expertise younger generation associate managementworker dialogue terumo recognizes healthy managementworker relationship based trust mutual understanding extremely important u grow develop together associate input worker union treated valuable feedback take action resolve issue way acceptable management associate dialogue top management take place meeting uc union company discussion side opportunity fully state view relationship terumo corporation annual report management worker union one work partner bring growth development company union member outside managementworker dialogue view freely exchanged throughout company survey conducted worker union feedback received using different channel data associate consolidated staffing data geographic area individual fy fy fy japan europe america asia others total associate gender location standalone data terumo corporation individual fy fy fy male japan female japan terumo corporation annual report providing safe workplace basic policy terumo group strive create safe workplace associatesvalued asset companycan realize full potential terumo employee called associate emphasize partnership collaborative working occupational health safety management structure protect safety associate japan occupational health safety management committee hold regular meeting factory rd headquarters sale office head office prevent industrial accident minimize impact occur continually undertake initiative aimed ensuring health safety workplace goal zero industrial accident initiative include program review danger zone risk mitigation measure information shared report committee others fiscal experienced industrial accident required associate take three day work three accident fiscal continue effort avoid industrial accident goal zero serious accident death industrial accident resulting lost working day frequency seriousness fy fy fy fy accident resulting lost working day frequency seriousness rate occurrence number accident resulting injury death per million working hour seriousness lost working day per working hour terumo corporation annual report employee health management terumos mission improve medical care society take various step protect health associate encourage aware health physical condition addition regular health checkup sponsor screening lifestylerelated disease mainly cancer cooperation health insurance union industrial health staff offer individualized health related guidance advice furthermore fiscal undertaken new initiative call terumo health action stimulate awareness dental health help associate avoid lifestylerelated oral health disease mouth well sponsoring dental health checkup provide subsidy care support towards treatment associate would like stop smoking unsuccessful receive stop smoking subsidy treatment smoking cessation clinic encourage associate try support succeed first time provide subsidy repeated attempt following year beyond support better mental health well physical wellbeing also offer variety lecture including stress management training new hire general employee team member mental health care management method leadership staff terumo corporation annual report compliance prevention harassment terumo group formulated terumo group code conduct sakura rule provides guidance aspect behavior conduct associate expected adhere daily business activity fulfilling role outstanding corporate citizen associate bear heavy social responsibility obeying law also demonstrating ethical behavior aspect work toward end terumo workplace hold annual event aimed promoting deeper understanding code conduct emphasizing compliance preventing harassment addition training incorporating example reflect familiar situation applied daily work regularly held management position understanding expected regarding harassment particular established system harassment victim receiving ethically questionable treatment immediately seek help male female responder provide advice internally protecting privacy seeking assistance system also make possible consult external attorney needed terumo corporation annual report promoting diversity basic policy respect human right stimulate diversity terumo group work hard promote respect individual culture discriminate whether race nationality gender religion disability basis would violate human right believe diversity associate powerful engine drive current future growth striving accept wide range differing value promoting mutual recognition diversity aim company differing idea knowledge intermingle creating new value established diversity promotion department work raise awareness diversity issue among associate continually promote diversity company variety perspective terumo employee called associate emphasize partnership collaborative working promoting active participation female associate first step channeling mutual recognition diversity corporate growth terumos top management made commitment promoting active participation female employee forged ahead various initiative aimed creating suitable environment climate awareness enable woman thrive workplace example include mentoring system woman seminar woman wanting resume career terumo mentoring system system pair female associate leadership position working different part company different age share experience idea broaden perspective support one another career growth raising awareness skill female associate woman assume leadership role within terumo contribute fresh perspective value fiscal group training womens creation mentoring system terumo corporation annual report career resumption seminar terumo seeing rising number men woman want continue career caring child providing nursing care fiscal began holding career resumption seminar female associate currently child nursingcare leave supervisor purpose seminar discus associate continue meet care responsibility returning work fiscal careerresumption seminar also career continue provide opportunity associate supervisor discus new way working furthering career fiscal conducted program aimed helping female manager improve mentoring skill bringing together female associate leadership position throughout japan group training also provided participant opportunity meet positive role model build support network fiscal conducted program aimed helping female manager improve mentoring skill bringing together female associate leadership position throughout japan group training also provided participant opportunity meet positive role model build support network number female manager terumo gradually rising march woman management position entire management staff continue advance initiative enable ambitious female associate play greater role terumo fiscal female manager seminar terumo corporation annual report number female manager figure terumo corporation japan operation japanese staff fulltime temporary assignment group company engagement people organization country promote better understanding japanese associate counterpart country hold waigaya event participant share information market work also different management practice also engage open wideranging discussion topic career path waigaya discussion associate australia japan terumo corporation annual report female associate working overseas career began terumo sale agent worked specialist dialysis product time rare healthcare professional take position within commercial business enormous challenge involved nearly entire range terumos offering course included hospital blood management product also charge radifocus guide wire product foundation portion cardiovascular business always confident ability build career example entered college program obtain degree marketing year completed degree gained opportunity work marketing manager since marketing manager terumo chile devising strategy seizing market opportunity driving home business plan analyzing result building relationship customer developing investment plansmy job many differing aspect love recently primary challenge increase sale argentina part call south cone southernmost part south america includes chile argentina uruguay paraguay also continue study take career next level marketing manager terumo chile ltda terumo corporation annual report rehiring system terumo expert system terumo introduced te terumo expert system fiscal way rehire retiree outstanding skill expertise many associate brought back te continue make expertise developed many year terumo expert work highly specialized area also wide range place contributing company drawing wealth experience provide guidance advice younger associate number percent associate rehired te employment people disability providing job opportunity fit capability aptitude individual terumo advancing employment people disability pursue rewarding life independent member society march people disability made workforce japan legally mandated rate looking future continue expand opportunity individual fully exercise capability terumo corporation annual report human resource development basic policy terumo belief true corporate value lie collective worth associate work company human resource development based practical skill acquired onthejob training ojt variety training program designed supplement ojt believe effective learning come interest associate heart therefore associate understand value necessity training self nominate various program terumo employee called associate emphasize partnership collaborative working terumo training scheme terumo global leadership meeting terumo global leadership program terumo corporation annual report promoting spirit monozukuri terumo promoting transfer skill experience monozukuri spirit veteran associate younger colleague devoted significant effort developing curriculum training environment instructor fiscal conducted training associate including participant overseas another step pursuit effort established production human resource development center april training vietnamese technician te associatesveteran employee rehired mandatory retirementlead nurturing younger generation moving forward aim globally accelerate development human resource taking key role production technology quality assurance management ensure monozukuri spirit keep thriving terumo global human resource development increasing globalization make essential terumo group develop highly motivated human resource equipped diverse communication skill needed work effectively people culture also necessary leadership capability japan terumo global leadership program tglp develops leader practical capability lead global business program involves participant aged selected around applicant series seminar held five month participant learn capture true nature management issue leadership challenge group discussion dialogue fiscal tglp closing ceremony associate relevant department participant develop proposal innovation way enhance current business presented terumos leadership successful proposal become actual high profile project terumo corporation annual report training international business skill japan terumo offer global challenge program international corporate program way associate gain international business skill relevant work experience program target young associate desire intent work abroad future international corporate program terumo sends associate emerging market country participant fiscal apply experience skill local organization set overseas work experience address social issue fiscal program participant spent program two month indonesia working ngo arranges medical clinic low income people addressing need hand participant also enlisted cooperation associate back japan support obtaining mba qualification terumo established system developing human resource suited global management support associate around world actively striving improve earning mba qualification system allows associate take leave long needed complete study allows take additional day unused paid leave prior start period leave study addition company may approve interestfree loan tuition living expense certain condition contribute towards entrance fee tuition also appreciate great benefit type opportunity provide mix people different company culture terumo corporation annual report worklife balance basic policy terumo aim increase work style flexibility hour location etc better enable associate work enthusiasm exercise capability fullest see employment system give rise flexible work approach system allow adjustment child care nursing care life event measure help associate meet home workplace responsibility step called act advancement measure support raising nextgeneration child continue take action need arise terumo employee called associate emphasize partnership collaborative working terumo corporation annual report child nursingcare support system following primary system place march help employee meet child nursingcare workplace responsibility child nursingcare support system system description child long term leave taken child reach age day care maternitypaternity unused paid holiday taken leave shortened working hour shortened hour per day child working hour finish elementary school approximately age adjusted working start end time regular working day moved forward hour backward hour child finish elementary school approximately age nursing special leave leave taken cumulative total year family care member requiring nursing care day unused paid holiday taken shortened working hour shortened hour per day cumulative working hour total year adjusted working start end time daily working hour moved forward backward hour hour cumulative total year hourbased paid paid leave may taken unit hour reason leave content excerpted child nursingcare support system nursingcare leave leave shortened working hour adjusted working hour used cumulative total year terumo corporation annual report approved display kurumin mark fiscal nextgeneration certification mark kurumin mark indicates company proactively pursues diversity terumo right display right display kurumin mark awarded japan ministry health labour welfare company recognizes formulated action plan helping employee meet child care need fulfill work family responsibility company approved use kurumin mark display product business card advertising swaddled infant mark design express willingness displaying company take step help employee raise child terumo committed fostering working environment associate approach work vigor free fully exercise capability encouraging men take childcare leave number male associate take childcare leave recently begun increase birth child prime opportunity rethink one approach work posting account associate taken childcare leave company intranet promote wider understanding system help create atmosphere make easier men choose participate child rearing terumo corporation annual report number associate taking maternity childcare leave standalone figure terumo corporation japan operation individual fy fy fy fy fy associate taking maternity leave associate taking childcare leave woman men workathome system terumo adopted workathome system give associate choice working home day childcare nursingcare responsibility make difficult come office committed expanding choice enable associate make skill knowhow demand associated child care nursing care example make working usual manner difficult careerreturn system terumo opened pathway rehiring associate left marriage child nursingcare responsibility relocation spouse careerreturn system expands range employment choice associate want resume career terumo supporting associate interrupt career return work making possible make good use broad experience skill contribute terumos growth noovertime day encouraging use paid leave terumo promotes work efficiency strict management time beginning workday establishment noovertime day part policy maintaining workplace environment work time work offtime rest set company holiday encourage associate take paid day terumo corporation annual report social contribution activity providing information manage health enlightening website preventing subarachnoid hemorrhage march terumo established enlightening website preventing subarachnoid hemorrhage japanese provide patient family accurate objective information cerebral aneurysm key cause subarachnoid hemorrhage content site assembled oversight dr nobuyuki sakai director neurosurgery stroke center kobe city medical center general hospital medical institution renowned treatment cerebral aneurysm purpose website promote correct understanding subarachnoid hemorrhage provide user useful prevention information diagnosed brain disease site provides latest medical information easy understand term help allay fear answer question terumo created numerous website providing information society large improve daily health management also created targeted website including devoted health topic body temperature another focused preventing fall among elderly enlightening website japanese explanation cerebral aneurysm key cause subarachnoid hemorrhage terumo corporation annual report contribution development healthcare terumo life science foundation first established terumo life science foundation relaunched registration public interest incorporated foundation april purpose foundation contribute medicine better health promoting advance life science technology subsidy form assistance three part foundation mission presentation ceremony first support life science research holding academic conference fiscal subsidy granted three special research project addressing topic regeneration approach using neovascularization inducing biomaterials treat brain injury general research project international exchange academic conference ceremony award subsidy recipient held march date foundation disbursed total practical lesson generating around billion subsidy recipient cellular sheet science café part second aspect missionawards related operationsthe foundation selected recipient second annual terumo global science prize commemorating th anniversary founding prize awarded outstanding researcher making unique contribution regenerative medicine biomaterials research winner second annual prize professor sung wan kim university utah professor kim formally presented prize presentation ceremony held july promoting education third aspect foundation mission japanese website called life science dokidoki research class created provide life science related information junior senior high school student today site provides young user easytounderstand information cuttingedge research researcher life science second book summarizing site content published terumo corporation annual report august foundation invited high school student seven prefecture kanto region attend event joint institution advanced biomedical science operated tokyo womens medical university waseda university participant science café able experience simulator example latest technology regenerative medicine greatly impressed fiscal activity similar conducted fiscal work contributing wider community presenting annual christmas gift hospice japan year around christmas time team terumo associate decorates outside wall terumo shonan center building christmas light christmas day team put firework display local community hospice terumo male choir sings christmas carol hospice patient program started bring christmas cheer hospice patient family local resident terumo male choir singing continued every year since christmas holiday season hospice able enjoy variety illumination display including one depicting reindeer illumination display firework terumo corporation annual report local activity terumo conduct many social contribution activity local community business site japan example terumo associate social contribution local activity weekly cleanup public road park near head office clean activity chuo ward tokyo held may cleaning tama river bank tokyo every spring fall cleaning surroundings shonan center cleaning surroundings fujinomiya factory cleaning surroundings ashitaka factory center cleaning surroundings sale branch note activity held fiscal offcampus learning assistance various terumo facility welcomed junior high school student taking part environmental study field trip student learned environmental initiative taken site environmental consideration incorporated product environmental activity undertake close home junior high school student afterward received many message student hosted offcampus happy learned terumos product learning experience importance protecting environment japanchina friendship initiative terumo cooperating project set give chinese university student chance visit japanese company understanding japan sponsored japanese chamber commerce industry china beijing japanchina friendship association project brought chinese student japan spring fall student tour terumo annually since occasion host student terumo corporation annual report one rotation six beijingarea university student visit medical pranex company headquarters plant research facility etc related member japanese chamber commerce industry china observe society industry including agricultural community culture aspect japan also meet japanese university student spend night japanese family farewell party terumo host visiting student tour terumo medical pranex experience medical training program aimed helping see medical device medicine different perspective terumo employee homestay host provide outstanding student guest first direct exposure daily custom culture japan giving future leader china chance experience delight warmth japanese culture believe chinese student interact people company japan deepen relationship two country lead greater friendship mutual understanding future terumo continue participation going forward donation aid typhoon victim philippine terumo donated syrinx medical device worth approximately million yen together financial contribution million yen aid victim typhoon struck philippine november addition subsidiary u europe southeast asia made donation money medical device total value around thousand dollar making donation embassy philippine terumo corporation annual report blood donation terumo carry annual blood drive factory branch japan fiscal total associate location across japan donated blood terumo contribution society include manufacture blood bag also blood donation activity inhouse blood donation terumo corporation annual report key characteristic medical device unlike pharmaceuticalsin effectiveness product determines therapeutic efficacyit optimal medical device used medical professional practice appropriate therapeutic technique high degree therapeutic efficacy obtained globalization taking hold activity medical professional numerous medical specialist nurse emerging region world study therapeutic technique u europe japan return home country share learned result product medical device coming demand new market globe efficacy device used field intervention intravenous therapy depends greatly manual dexterity medical professional using therefore improving product usability critical monozukurior art manufacturingperspective importance medical professional simply growing accustomed using cannot underestimated terumo belief disseminating advanced medical technology academic information product also training duty medical device manufacturer whose product choice medical professional across globe supporting development healthcare professional throughout world mock hospital equipped latest device terumo opened terumo medical pranex comprehensive medical training facility within rd center assist healthcare professional throughout world improve skill replete various type simulator operating room realworld facility catheterization laboratory terumo medical pranex essentially mock hospital faithful recreation medical environment improvement coronary neurovascular intervention therapy skill safety improvement emergency response hospital home even basic skill new nurse facility one meticulous training undergone realistic medical environment used around healthcare professional around world every year terumo corporation annual report working jica promote tri central south america interventional system division terumos cardiac vascular company submitted proposal japan international cooperation agency jica initiation project promotion private sector technology toward social economic development developing country publicprivate partnership project proposal selected among many competitor terumo japanese medical institution commissioned jica conduct training use transradial coronary intervention tri interventional treatment u blood vessel wrist entry point approaching coronary artery training provided period two year medical professional mexico colombia argentina brazil four country technique used relatively infrequently purpose project promote adoption tria treatment technique mean less physical stress patient lower medical expensesin country heart disease become serious problem contribute better health country increasing treatment rate people heart disease also thought initiative project could contribute friendly relationship japan participant country first phase project physician mexico colombia came japan may participate training terumo corporation annual report disseminating information efficacy safety new technology product terumo gather widely disseminates academic information broad variety medical field every year actively participate academic conference held medical professional across globe use opportunity disseminate information latest therapeutic technique product physician specialist live demonstration specialist conference interventional therapy conference presentation clinical trial widely distribute information utility new product efficacy therapy furthermore field general hospital business academic conference provide information new therapy technique safety operational efficiency improvement initiative topic effort also extend patient family reach channel like health information website site began march example posted information subarachnoid hemorrhage topic well understood general public site offer easily understood explanation characteristic treatment prevention cerebral aneurysm cause subarachnoid hemorrhage disseminating objective accurate information contributing proper treatment health problem terumo corporation annual report environment ehs management goal achievement material flow developing environmentallyfriendly safety product initiative deal climate change effective use resource proper control chemical substance initiative biodiversity conservation environmental data fiscal history environmental initiative terumo corporation annual report ehs management formulation terumo global ehs policy october revised basic environmental policy instituted terumo global ehs environment health safety policy outline stance reducing impact business activity environment conserving biodiversity health safety associate work policy applies entire terumo group form basis corporate activity information occupational safety health initiative please refer following page terumo global ehs policy terumo group aim good corporate citizen striving reduce environmental impact associated business activity ensure safety health employee based corporate mission contributing society healthcare take action based environmental health safety ehs management system establish following voluntary goal strive continuous improvement reduce environmental impact ehs risk business activity develop environmentally friendly safe product effectively use appropriately manage energy resource comply law ordinance agreement rule relating ehs country carry environmental conservation activity strive conserve biodiversity member society community work ensure safety health employee business activity strive create safe comfortable work environment strive prevent ehs accident environmental pollution occupational injury emergency strive prevent damage spreading responding swiftly appropriately systematically continuously provide education training strive increase ehs awareness actively disclose information pertaining ehs activity strive communicate society community established october ehsenvironment health safety terumo corporation annual report ehs management system established line terumo global ehs environment health safety policy ehs policy developing ehs management system integrate approach issue ehs policy related target plan deliberated decided ehs committee key part terumos focus sustainability business reflected ehs activity terumo group site worldwide ehs expert subcommittee formed provide advice ehs committee key area addition ehs audit committee oversees conduct ehs related internal audit site confirm effectiveness operational status system well compliance relevant law regulation going forward focus continuous system improvement gradually acquire iso certification environmental management system ohsas standard occupational health safety management system terumo group production site fujinomiya factory fujinomiya city shizuoka prefecture terumo penpol ltd kerala india obtained certification fiscal companywide organization promoting ehs management system terumo corporation annual report iso ohsas certification gained fujinomiya factory fujinomiya factory created ehs management system manage environmental health safety matter integrated fashion based terumo global ehs policy obtained iso environmental management ohsas occupational health safety management certification october fujinomiya factory committed maintaining continuously improving management system lower environmental impact manufacturing activity secure health safety everyone working premise ehs audit prevent legal violation environmental problem reduce present future environment safety health risk conduct internal ehs audit based terumo ehs committee standard audit cover factory rd center head office sale office japan well terumo group company including overseas site audit task check operational status ehs management system check compliance ehsrelated law ordinance check ehsrelated performance audit identifies instance noncompliance request corrective preventive actionsresponse form issued followup check performed ensure corrective preventive action implemented functioning matter constitute noncompliance thought warrant ongoing observation written followup check performed matter question reviewed following year audit terumo corporation annual report fiscal ehs internal audit result regarding compliance ehsrelated law ordinance serious violation four minor violation identified corrective preventive action implemented regarding management environmental risk item individual business site determined efficient management system place serious effort made achieve voluntary goal internal audit terumo china regarding occupational health safety holding co ltds hangzhou plant matter currently addressed determined action taken result improvement result external environmental audit fiscal auditing wastetreatment contractor confirm sludge waste plastic generated terumo appropriately processed throughout stage treatment prepared checklist use regular audit waste collection disposal contractor fiscal conducted audit contractor audit wastetreatment contractor result external onsite inspection fiscal prefectural municipal authority conducted environmental onsite inspection tested water sample factory rd center based water pollution control act air pollution control act waste disposal public cleansing law act confirmation etc release amount specific chemical substance environment promotion improvement management inspection government thereof inspection test resulted issuance authority remedial instruction inspection authority terumo corporation annual report ehs education environmental safety training associate ensure solid understanding terumo global ehs policy ehs activity everyone terumo expected engage conduct training tailored sale production type business site associate including new hire required participate promote greater environmental health safety awareness also distribute information via terumo intranet hold ecocampaigns associate associate ehs training family ehs award systemterumo humanecoaward created terumo humaneco award system fiscal recognize environmental safety health contribution element terumo group worldwide award encourage associate become involved environmental safety health activity share related information initiative selected award ceremony recognition fiscal listed example shared throughout terumo group project award recipient resource saving filter used remove white blood cell fujinomiya factoryrd headquarters energy saving change air conditioning control ashitaka factory approach building terumo corporation annual report goal achievement environment safety performance fiscal voluntary fiscal fiscal initiative fiscal target targetsmediumterm assessment target begin application management system integrating introduce group environmentalsafety environmental health health coverage expand application safety management view toward group system ehsms gaining rdparty ehsms kofu domestic production site certificationfujinomiya factory obtain rdparty ehs factory certification management system continue internal construction terumo group ehs audit conduct environmental expand application move forward health safety group ehsms creation compliance training principal overseas global ehsms production site manual assemble information legal revision terumo corporation annual report fiscal voluntary fiscal initiative fiscal target fiscal target targetsmediumterm assessment continue operating workrelated workrelated death workrelated death serious death serious serious accident accident accident cut workrelated fewer accident cut workrelated accident half requiring time accident compared compared fy previous previous fiscal reduction fiscal year year accident risk continue environmental develop procedure continue operating impact assessment responding serious environmental environmental accident continue risk accident assessment emergency continue develop achieve concrete product comply result rohs development bring directive build planning least humaneco product assurance one humaneco development market system productproduction process terumo environmentally advance corporation japan conscious development development site safe product product reflect production consideration advance cooperation process humaneco among business site develop technology development production use cfc directive technology environmental use cfc hcfc safety concern terumo corporation annual report fiscal voluntary fiscal fiscal fiscal initiative targetsmediumterm target assessment target improve co advance effort emission per unit save energy consolidated net reduce electricity sale usage reduce co compared emission per unit previous fiscal year participate consolidated net sale challenge relative reduce energy campaign fy business cost implement internal location japan compared bau eco campaign overseas terumo manufacturing site corporation promote eco effective use manufacturing driving energy longterm target research site resourcesreduction reduce japan reduce final co emission fy disposal waste bau business less usual period total waste action business location taken excluding sale office japan reduce final increase waste disposal waste recycling advance use less higher group electronic total waste terumo company japan manifest corporation overseas throughout business location manufacturing site group japan terumo corporation annual report fiscal voluntary fiscal initiative fiscal target fiscal target targetsmediumterm assessment determine status chemical substance establishment management chemical substance prepare guideline maintain management system terumo dichloromethane compliance guideline corporation release less business location proper japan continue voluntarily control measure property line chemical keep move forward effort concentration substance dichloromethane control release ethylene oxide emission less property line reduction per year concentration continue comply emission eog dichloromethane reach concentration chemical substance overseas property line chemical substance adjacent improve work regulation residential area environment organic solvent μgm business handled location japan terumo corporation annual report fiscal voluntary fiscal fiscal initiative fiscal target targetsmediumterm assessment target conduct internal work ngo eco campaign advance expand continue mt fuji expand participation biodiversity preservation reforestation project business location activity preservation japan biodiversity continue employee expand mt fuji participation eco expand mt fuji reforestation project activity reforestation include ongoing care project planted tree include social environmental reporting issue social annual report environmental improve quality enhancing content report annual report information process disclosure conduct advancement integrate economic environmental ehs social month initiative communication environmental information continue environmental implement ehs construct ehs e safety education education applying learning system associate elearning business location business location japan japan terumo corporation annual report material flow energy raw material input use identify environmental impact term co wastewater waste output business activity use data indicator activity aimed reducing environmental impact going forward material flow related terumos business activity business activity material flow data terumo corporation operation japan coefficient used calculating co emission related electricity use provided electric power provider prtr pollutant release transfer register distributionrelated nox emission calculated using coefficient japanese environment ministry environmental activity evaluation program april terumo corporation annual report developing environmentallyfriendly safe product goal healthcare friendly people environment terumo develops product friendly healthcare professional patient global environment humaneco development guideline terumo aim make medical treatment kinder gentler mean making medical procedure safer efficient creating technology place less physical stress patient prevent infection facilitate work medical professional lead medicine friendly environment infection medical accident occurs becomes necessary use medical resource would needed otherwise believe therefore developing product emphasize safety efficiency usage well effectiveness good environment terumo established humaneco guideline set four principle directive developing product friendly people environment promote effort display humaneco logo best example design philosophy humaneco development guideline terumo corporation annual report measure hazardous substance pioneer removal mercury healthcare practice conference plenipotentiary minamata convention mercury held october convention adopted signed convention take effect essentially prohibit manufacture import export product containing mercury terumo ceased production mercury thermometer year since developed digital thermometer digital blood pressure monitor device mercuryfree safer people friendlier environment digital thermometer digital blood pressure monitor promoting pvcfree dehpfree product terumo help reduce release toxic gas incineration polyvinyl chloride pvc promoting use pvcfree packaging also use alternative di ethylhexyl phthalate dehp whenever possible since concern may biologically harmful iv solution set iv solution bag cardiovascular circuit terumo corporation annual report saving resource cost minimally invasive economical cardiac catheter introducer kit cardiac catheterization performed inserting catheter either wrist groin inserting wrist entail fewer complication postprocedure bleeding less invasive terumo developed innovative introducer kit feature sheath thinner finely formed wall smaller outside diameter narrower sheath make treatment option available patient small artery cardiac catheter introducer kit also reducing cost resource usage associated post procedure complication ptca balloon catheter various type therapy developed ptca balloon catheter used various type therapy using advanced material improving way balloon folded product made possible reduce number catheter used provide treatment patient mean comfortable patient help save resource reduces treatment expense ptca balloon catheter ptca balloon catheter medical device used widen clogged blood vessel inflating balloon tip terumo corporation annual report integrationthick liquid meal need water adjustment unlike conventional product fluidity thickness must adjusted creating need bottle readytouse product produce less waste eliminates labor associated washing bottle moreover mixture water thick liquid nutrition reduces burden healthcare professional caregiver humaneco certified thick liquid meal integrationcombining several drug one bag product put infusion liquid required single bag simplifies mixing process help prevent microbial external contamination coinjection also eliminating potential accident involving needle product also help save resource reduce medical waste eliminating need medical equipment used preparing infusion bag fiscal introduced version infusion solution product mechanism prevent administration liquid separate compartment bag mixed safely infusion fulcaliq registered trademark mitsubishi tanabe pharma corporation integrationprefilled syrinx prefilled syrinx eliminate need suction dissolution also replace ampoule vial besides boosting productivity also help prevent microbial contamination problem due syringe misidentification accident involving needle made plastic prefilled syrinx less fragile easier dispose term waste separation weight compared glass syrinx injection solution prefilled syrinx terumo corporation annual report integrationoxygenator integrated arterial filter integrating oxygenator arterial filter one device reduced number part used blood circuit well material used oxygenator integrated arterial filter lighter smaller product reduced size weight syrinx maintaining volume functionality improvement enabled reduction waste term weight reduction size also reduced cost packaging transportation also achieved reduction weight continuous syringe capd bag ambulatory peritoneal dialysis capd bag used home healthcare effort reduce household waste flexible portable blood bag used country aiming improve safety transfusion terumo marketed first blood bag produced japan compared product made glass terumos plastic bag incorporating blood collection tube container offer outstanding flexibility portability reducing transportation cost well waste volume blood bag terumo corporation annual report packaging waste volumeweight reduction developed certified angiographic kit eliminated excess packaging procedure providing product needed surgery together single set reduced weight waste developing better method form product packaging redesigning shape tray allowed reduction material compared terumos conventional solution pack humaneco certified angiographic kit easier use safer improving usability patientsblood glucose monitor voice guidance device large easily readable lcd screen voice guidance feature enable user hear reading error message raised button separated easy distinguish touch ensure diabetic patient impaired sense vision touch use device easily product gained good design award fiscal blood glucose monitor closed infusion system chemotherapy drug reduces exposure risk chemotherapy drug help control cancer many reported pose potential risk health handling due carcinogenicity terumo chemoshield system infusion chemotherapy drug eliminates risk closed system prevent exposure drug process administration disposal since need use needle prepare infusion system enhances closed infusion system safety medical personnel preventing risk needle chemotherapy drug accident terumo corporation annual report initiative deal climate change climate change due global warming among critical environmental problem threatening humanity unusual weather event expected cause increase natural disaster impact ecosystem way serious health impact terumos business activity also subject greater risk working prevent global warming using energy effectively applying renewable energy taking step help prevent climate change target reduction co emission scope global co emission fiscal equivalent emission per unit net sale fiscal significantly better comparable figure fiscal nearly co emission accounted production plant rd center ehs expert subcommittee energy take lead planning advancing energy efficiency global warming measure later implemented individual business site fiscal invested mainly fuel conversion turbo chiller highefficiency oncethrough boiler led lighting efficiencyboosting device also repaired steam leak took energysaving measure based regimen regular inspection implemented simple yet effective energysaving measure office including setting thermostat appropriately turning unneeded lighting holding ecocampaigns involve entire terumo group energysaving scope terumo u ghg protocol scope standard calculate greenhouse gas emission scope standard direct emission greenhouse gas corporate facility plant scope standard indirect greenhouse gas emission associated consumption purchased electricity scope standard terumo employ greenhouse gas emission business activity global business site japan overseas production site mid longterm goal global reduce co emission per unit consolidated net sale relative fiscal level fiscal terumo corporation annual report trend co emission per unit consolidated net sale co emission breakdown scope scope emission fy business site japan overseas production site electricityrelated co conversion coefficient japan set based actual result obtained individual customer fy overseas electricityrelated co conversion coefficient regional coefficient published iea co emission fuel combustion co emission breakdown scope scope emission fy scope scope total japan overseas global renewable energy usage photovoltaic power mwh biomass gaskg terumo corporation annual report initiative fujinomiya factory fujinomiya factory fujinomiya city shizuoka prefecture u large amount steam sterilize product considering way increase steam supply efficiency replaced flueandsmoketube boiler high efficiency highpressure oncethrough boiler combined highefficiency high deactivators new approach supplying steam pressure oncethrough boiler much responsive load change helped u increase steam supply efficiency around also produced fuel saving kl reduced co emission roughly ton effort terumo penpol limited terumo penpol limited state kerala india installed biogas plant use resource efficiently improve energy efficiency renewable energy using food waste company cafeteria generate biogas used prepare food cafeteria efficiently put waste use creating energy cutting biogas plant co emission effort reduce environmental impact distribution scope terumo switching truck marine transportation improving carry efficiency distribution vehicle undertaking measure lighten environmental impact distribution terumo corporation annual report improved transportation efficiency infusion product improved stacking efficiency infusion product reduce co emission transport stage changing specification product packaging bag using greatly improved package shape resulted gain stacking capacity per pallet reducing environmental impact logistics operation important continue look way achieve higher level carry efficiency improving carry efficiency pallet level terumo corporation annual report co emission scope terumo corporation annual report effective use resource earth limited resource make terumos business activity possible therefore strive utilize needed resource effectively efficiently activity associate including wastereduction effective resource utilization improved recycling making effort reduce amount landfill waste manufacturing process business activity factory rd center office generate variety waste therefore set target keeping landfill waste less total amount waste generated site japan ensure achieve reduction target urge proper sorting waste continue refine waste disposal method rule fiscal total waste volume disposed landfill meaning achieved target tenth consecutive year target reduction landfill waste reduce amount landfill waste less total amount waste generated site japan terumo corporation annual report trend amount landfill waste generated japan breakdown total waste generated fy terumo group operation japan reducing packaging effective use resource improved usability terumo making effort reduce packaging material without impairing functionality effort include developing smaller lighter slimmer package reviewing package design terumo corporation annual report reducing paper used semisolid nutritional liquid meal adopting less compressible octagonal packing container able use thinner cardboard eliminate partition change cut amount paper used packaging removal partition also make cardboard easier fold saving disposal space customer reduction cardboard volume addition improved container design eliminates need use packing tape reducing weight waste reducing amount paper used packaging promoting recycling industrial waste sc one ehs expert subcommittee play big role sharing important information among site associate make effort recycle due unique property product safety concern usually possible recycle product use medical product however recycle various type waste generated production process officebased business activity use plastic product including floor tile recycled plastic fuel rpf organic fertilizer fiscal recycling rate reached japan terumo corporation annual report recycling amount rate japan recycling amount rate global japan terumo group business location japan global terumo group business location japan overseas production site initiative recycle small rechargeable battery continue recycle small rechargeable battery accordance act promotion effective utilization resource japan portable rechargeable battery recycling center terumo corporation annual report jbrc promotes recycling small rechargeable battery collect recycles small rechargeable battery terumo product made several improvement simplify recycling separation process including displaying recycling logo addition collect recycle sealed leadacid battery replace maintenance collection recycling performance fy april march kg nickelcadmium nickelhydride lithiumion sealed leadacid battery effective utilization water resource terumo optimize use water resource measure circulating reusing cooling water although expect production level continue rise make every effort utilize water resource effectively water use japan terumo corporation annual report proper control chemical substance guided terumo global ehs policy terumo monitor control use emission disposal chemical substance according voluntary target leadership chemical substance subcommittee one ehs expert subcommittee work track reduce handling emission chemical substance target reduction chemical emission initiative aimed reducing dichloromethane emission reduce dichloromethane emission installed recovery equipment kofu factory working bring emission voluntary target less ton per year target japan keep dichloromethane emission less ton per year terumo corporation japan business location dichloromethane emission terumo corporation annual report initiative reduce ethylene oxide emission ethylene oxide widely used sterilize medical device terumo working reduce ethylene oxide emission outside environment installed catalytic oxidation emission treatment system ashitaka fujinomiya factory shonan center along combustion treatment equipment kofu factory also working alternative ethylene oxide sterilization ethylene oxide emission data terumo corporation standalone business location japan alternative hcfcb response montreal protocol japan prohibited domestic manufacture hcfcb terumo established hcfc network chemical substance subcommittee year following network comprised representative factory worked alternative hcfcb involved listing process use substance sharing information alternative sharing result study undertaken various site end completed manufacturing change accommodate alternative using bcontaining material already purchased although continue consume instock material purpose needing small amount substance b emission gradually decrease zero terumo corporation annual report hcfcb emission data terumo corporation standalone business location japan ghs initiative terumo provide ghs based information hazardous chemical substance associate handle chemical substance promotes proper handling chemical substance ultimately protects environment health associate also gather data prtr substance monthly basis work reduce source emission number one priority ghsglobally harmonized system classification labelling chemical prtr pollutant release transfer register terumo corporation annual report management prtr substance substance volume fujinomiya ashitaka kofu rd total factory factory factory ethylene oxide gas amount used eog emission amount transferred dichloroethane amount used emission amount transferred hcfcb amount used emission amount transferred hcfc amount used emission amount transferred dichloromethane amount used emission amount transferred toluene amount used emission amount transferred terumo corporation annual report substance volume fujinomiya ashitaka kofu rd total factory factory factory di ethylhexyl amount used phthalate dehp emission amount transferred hydrogen fluoride amount used emission amount transferred bromopropane amount used emission amount transferred nhexane amount used emission amount transferred nndimethylformamide amount used emission amount transferred terumo corporation annual report green procurement terumo must respond wide variety demand customer government authority regarding substance control regulation various country nature medical device concern allergy endocrine disruptors cooperation among relevant department terumo working respond request building forward looking system monitoring controlling hazardous substance compliance chemical regulation worldwide reach etc response increasingly strict chemical regulation worldwide terumo developing regulatory compliance system cope future change cooperation among relevant department collection regulatory information environmental management department aggregate information environmental regulation obtained government bulletin activity industry europe advanced chemical regulation country local subsidiary also provide regular report centralizing management information terumo work ensure aware survey targeted substance regulatory response check design phasesupplier survey product design stage designer informed regulated substance refrain using environmental pollutant wherever possible use human x eco development guideline tool raise designer awareness meanwhile quality assurance department section charge material procurement cooperate investigate amount regulated substance contained material procured material investigation conducted form comprehensive survey serf wide variety purpose cover item necessary assuring product quality survey result become available quality assurance department enters database use data immediately needed terumo corporation annual report humaneco development guideline feedback local site ensure local site comply regulation environmental management department provides information local subsidiary related department feedback local site aiming appropriate pcb management accordance japan law concerning special measure promotion proper treatment pcb waste waste management public cleansing law removed transformer fluorescent light ballast equipment containing pcbs japanese facility ensure prompt appropriate disposal material completed early registration toyota office japan environmental safety corporation jesco pcb polychlorinated biphenyl terumo corporation annual report initiative biodiversity conservation line commitment biodiversity conservation terumo promotes activity support development lowcarbon recyclingoriented society human coexist nature mt fuji reforestation projectterumo meguminomori terumo two factory fujinomiya city shizuoka japan take water spring foot mr fuji use production process medical device pharmaceutical product recognizing use natural resource conduct business undertaken terumo mt fuji reforestation project protect area project conduct reforestation using indigenous tree part mt fuji forest lost many tree typhoon helping become resistant future natural disaster ensuring continue serve source groundwater since fiscal terumo also entered agreement shizuoka prefecture local forest owner called shizuoka mirainomori future forest supporter pact agreement plant tree maintain forested area create terumo meguminomori reserve within fumoto district fujinomiya agreement term location ha forested area designated landowner fumoto district activity fujinomiya type activity forest maintenance agreement duration year initiative fiscal november terumo associate family member numbering came together plant tree group planted maple beech dogwood tree indigenous area installed shelter around sapling prevent grazing deer terumo corporation annual report volunteer tree planting terumos eco challenge volunteer campaign every summer since held eco challenge campaign volunteer terumo associate japan family hold variety environmental conservation activity home work challenge sheet describing specific eco activity distributed participant perform point sunflower grown eco calculated based activity participating associate challenge participant terumo u resulting figure determine size donation organization industrial spiritual cultural advancementinternational oisca fiscal total associate participated eco challenge held together lookhowyouvegrown program participant presented minisunflower seed object combined activity raise ecological awareness participant family planting seed photographing growth sharing photo company intranet terumo corporation annual report program receiving donation terumo childrens forest program childrens forest program encourages child get involved greening activity cultivate love nature learn importance forest nurturing seedling school ground community fund donated terumo used provide environmental education child philippine expand woodland planting nurturing seedling activity project restore coastal forest coastal forest play important role preserving local living condition acting sand wind barrier damper tsunami loss coastal forest due tsunami generated great east japan earthquake salt damage along coast tohoku region growing worse project restore coastal forest intended promote expanded production seedling planting nurturing forestland project also work recovery disaster affected region farmland restoration job creation terumo corporation annual report environmental data fiscal green purchasing result unit yen stated thousand head office sale overall green purchase operation purchase unit cost unit yen stated thousand factory overall green purchase purchase unit cost site data manufacturing research site fiscal site location co water total hazardous recycled emission usage waste waste amount fujinomiya factory fujinomiya shizuoka japan ashitaka factory fujinomiya shizuoka japan kofu factory nakakoma yamanashi japan ashigarakami kanagawa rd center japan terumo clinical supply co kakamigahara gifu japan ltd terumo corporation annual report site location co water total hazardous recycled emission usage waste waste amount terumo medical corporation tcvs maryland usa tcvs terumo heart inc michigan usa tcvs massachusetts usa harvest technology corporation massachusetts usa microvention inc california usa onset medical corporation california usa nd nd nd nd terumo bct inc colorado usa microvention costa rica srl san jose costa rica terumo europe nv leuven belgium terumo europe nv liverpool uk uk plant vascutek ltd glasgow uk vascutek ltd leeds uk terumo bct inc larne uk terumo medical product hangzhou zhejiang china co ltd changchun terumo medical product jilin china co ltd laguna terumo philippine corporation philippine terumo penpol ltd kerala india terumo vietnam co ltd vinh phuc vietnam tcvs terumo cardiovascular system corporation waste density used calculation tm general waste industrial waste tm hazardous waste coefficient used calculating co emission related electricity use provided electric power provider however coefficient business site marked geographic emission coeff icients presented iea co emission fuel combustion figure marked revised april terumo corporation annual report history environmental initiative environmental control department established ashitaka factory sedimentation system replaced chelating adsorption system treat water effluent containing mercury general water effluent treatment facility installed fujinomiya factory acid surface treatment needle hub base needle discontinued favor plasma treatment system generate acid wastewater fujinomiya ashitaka factory sign pollution control agreement fujinomiya city boiler fuel fujinomiya factory switched heavy oil lpg contains less sulfur syringe gasket material switched rubber thermoplastic elastomer prevent generation sulfur oxide incineration general water effluent treatment facility installed ashitaka factory ethylene vinyl acetate eva generate toxic gas incinerated adopted replace pvc polyvinyl chloride material iv solution terupack container use trichloroethylene discontinued ahead regulation gamma ray sterilization emit harmful gas adopted sterilization system kofu factory market launch nonmercury digital thermometer year mercury thermometer production discontinued promote use safer mercuryfree medical product glass vacuum blood collection tube replaced tube made polyester disposed incineration market launch nonpvc hypodermic administration set using polybutadiene generate hazardous gas incinerated market launch digital blood pressure monitor hospital promote use safer mercury free medical product market launch balloon catheter made thermoplastic elastomer generate sulfur oxide incinerated terumo corporation annual report use ozonedepleting specified chlorofluorocarbon cfc chemical eliminated kofu factory production process action later taken factory production started hypodermic administration set new type needle made plastic simplifies postdisposal separation hospital enables disposal incineration environmental management department established head office cogeneration combined heat power chp adopted cover power need kofu factory fuel fujinomiya ashitaka factory switched lpg city gas emits less co use heavy oil discontinued production site smaller lighter syrinx introduced enabling reduction waste weight use recycled copier paper implemented catalytic oxidation treatment system adopted eog emission treatment fujinomiya factory terumos basic environmental policy established cogeneration implemented fujinomiya factory recycled paper adopted use catalogue specification change notification nonpvc solution container adopted use athome continuous ambulatory peritoneal dialysis therapy polypropylene container generate hazardous gas incinerated enable reduction waste weight adopted environment committee established cogeneration implemented ashitaka factory packaging container identification mark recyclable material implemented internal environmental audit implemented use dieselpowered work vehicle discontinued first edition nowannual environmental report published use incinerator discontinued kofu ashitaka factory pcbcontaining device equipment removed put storage market launch pediatric nonpvc hypodermic administration set associate family member participate mt fuji cleanup activity use benzene chloroform discontinued kofu factory kofu ashitaka factory discontinue use dismantle incinerator cleanup mt fuji conducted joint activity kofu fujinomiya area participant observation well installed kofu factory monitor groundwater quality market launch hypodermic administration set using totm alternative dehp plasticizer terumo corporation annual report zero waste emission achieved ashitaka factory head office switch lpg city gas kofu factory completes fuel conversion major site japan onsite inspection conducted overseas site terumo mt fuji reforestation project launched terumos highcalorie electrolyte infusion fluid vitamin glucose amino acid receives president prize eco product promotion council first ecoproducts award zero waste emission achieved kofu fujinomiya factory zero waste emission achieved shonan center market launch digital blood pressure monitor compliant rohs directive turbo refrigeration unit introduced kofu factory catalytic oxidation treatment system adopted eog emission treatment ashitaka factory terumo join team minus fujinomiya factory presented director general prize kanto bureau economy trade industry award outstanding energy conservation factory additional catalytic oxidation treatment system eog emission treatment installed ashitaka factory test plant installed liquefaction waste plastic human x eco development guideline adopted environmental auditing introduced overseas production site fujinomiya factory recognized excellence supporter ecoship modal shift project additional catalytic oxidation treatment system eog emission treatment installed fujinomiya factory solar power generation system introduced fujinomiya factory kofu factory presented highest prize kanto electricity efficiency committee chair award additional catalytic oxidation treatment system eog emission treatment installed ashitaka factory power management system providing graphic feedback adopted japanese business site high electricity consumption agreement benefitting forest shizuoka entered shizuoka prefecture japan local forest owner terumo europe haasrode plant gain iso ohsas certification terumo corporation join united nation global compact terumo global ehs policy established rd center japan presented highest prize kanto electricity efficiency committee chair award fujinomiya factory terumo penpol ltd gain iso ohsas certification terumo corporation annual report director audit supervisory board member executive officer september director koji nakao yutaro shintaku chairman representative director president representative director hiroshi matsumura takayoshi mimura akira oguma hideo arase director executive vice president director senior managing executive officer director senior managing executive officer director senior executive officer president general hospital company regional representative china general affair dept regional representative latin america president ceo terumo china holding supply chain management dept president ceo terumo america holding co ltd planning dept procurement dept inc terumo call center kuniko shoji toshiaki takagi shinjiro sato david perez director senior executive officer director senior executive officer director senior executive officer director senior executive officer general manager regulatory affair dept quality assurance dept president cardiac vascular company president blood management company clinical development dept postmarket surveillance vigilance dept president ceo terumo bct inc environmental management dept tadao kakizoe mari matsunaga ikuo mori independent director independent director independent director president japan cancer society representative mari matsunaga office inc advisor fuji heavy industry ltd terumo corporation annual report audit supervisory board member kenji sekine yoshiaki shiraishi toshihiko matsumiya masatake yone audit supervisory board member audit supervisory board member audit supervisory board member audit supervisory board member fulltime fulltime external external certified public accountant lawyer executive officer kazuaki kitabatake narushige toda shouji hatano yoshiaki akaike senior executive officer senior executive officer senior executive officer senior executive officer regional representative india asia general manager sale division japan general manager strategic planning dept vice president general hospital company pacific general hospital company design planning dept vice president pharmaceutical nutrition managing director terumo asia holding division production general hospital pte ltd company international business dept investor vice president dd division production relation corporate communication dept general hospital company legal dept factory manager fujinomiya pharmaceutical factory general hospital company general manager production dept tsuyoshi tomita mark sutter toru kubota somsak jarasviriyagul senior executive officer executive officer executive officer executive officer vice president general hospital company division president cv system division president terumo philippine corp representative director terumo thailand general manager business structural cardiac vascular company co ltd improvement office general hospital president ceo terumo cardiovascular company system corp kyo nishikawa hiroshi nakagomi masataka haraguchi juichi takeuchi executive officer executive officer executive officer executive officer regional representative eastern europe general manager quality assurance dept branch manager tokyo branch division president dd division overseas russia middle east africa general hospital company managing director bod chairman terumo europe n v minoru suzuki richard cappetta seiji kawabata maki takizawa executive officer executive officer executive officer executive officer general manager planning dept division president neurovascular division division president general hospital product division president general hospital product cardiac vascular company division japan general hospital company division overseas general hospital president ceo microvention inc company masato nishimura hiraku murayama ryo nishihata kosuke matsumoto executive officer executive officer executive officer executive officer general manager production technology vice president interventional system general manager treasury dept general manager human resource dept center production dept division production cardiac vascular controller dept human resource development dept company factory manager ashitaka factory cardiac vascular company masanori hoshino hiroshi nagumo jim rushworth hiroaki kasukawa executive officer executive officer executive officer executive officer president terumo clinical supply kk senior vice president general manager regional president u interventional general manager rd headquarters japan terumo bct holding corp system division cardiac vascular intellectual property dept president representative director company terumo medical pranex terumo bct kk president ceo terumo medical corp yoshihiro kimura takanori shibazaki hikaru samejima executive officer executive officer executive officer general manager internal audit dept general manager supply chain management division president interventional system dept division cardiac vascular company terumo corporation annual report major consolidated subsidiary september japan america terumo clinical supply co ltd gifu terumo america holding inc usa terumo yamaguchi corp yamaguchi terumo medical corp usa terumo heart kk tokyo terumo cardiovascular system corp usa terumo latin america corp usa terumo medical de mexico sa de cv mexico terumo panama international inc panama terumo medical brasil ltda brasil terumo chile ltda chile terumo colombia andina sa colombia microvention inc usa terumo heart inc usa terumo bct holding corp usa terumo bct inc usa microvention costa rica srl costa rica onset medical corp usa terumo mexico service sa de cv mexico cardiac vascular business general hospital business blood management business holding company factory terumo corporation annual report europe china terumo europe nv belgium terumo medical product hangzhou co ltd china terumo deutschland gmbh germany terumo china hong kong ltd china laboratoires terumo france sa france terumo medical shanghai co ltd china terumo italia srl italia terumo china holding co ltd china terumo europe españa sl spain terumo sweden private ab sweden terumo uk ltd united kingdom asia vascutek ltd united kingdom vascutek deutschland gmbh germany terumo philippine corp philippine microvention uk united kingdom tp estate inc philippine microvention europe france terumo marketing philippine inc philippine microvention deutschland gmbh germany terumo thailand co ltd thailand terumo bct europe nv belgium terumo vietnam co ltd vietnam terumo russia llc russia pt terumo indonesia indonesia terumo bct ltd united kingdom terumo korea corp korea terumo penpol ltd india terumo mauritius holding ltd mauritius terumo asia holding pte ltd singapore terumo singapore pte ltd singapore terumo malaysia sdn bhd malaysia terumo australia pty limited australia terumo vietnam medical equipment co ltd vietnam terumo bct vietnam co ltd vietnam terumo india private ltd india terumo corporation annual report corporate information september tokyo office tokyo opera city tower nishishinjuku shinjukuku tokyo japan head office hatagaya shibuyaku tokyo japan founded september capital billion yen employee nonconsolidated march terumo group website wwwterumocom annual report wwwterumocominvestorlibraryannualreport investor information march number share authorized number share issued number stockholder stock exchange listing first section tokyo stock exchange security code trading unit share terumo corporation split share common stock two share effective st april composition issued share type stockholder major shareholder top shareholder number percentage treasury share share held total thousand share issued master trust bank japan ltd trust individual others trust bank japan trustee service bank ltd trust banking company daiichi life insurance company limited meiji yasuda life insurance company number foreign share issued company tokio marine nichido fire insurance co ltd mizuho bank ltd financial institution olympus corporation mitsubishi ufj trust banking corporation terumo life science foundation company security company bnp paribas security japan limited terumo terumo bct misago hiryu nobori ultimaster nanopass surflo surplug chemoshield f light terumeal lunawave hr joint acelio glide sheath slender registered trademark terumo corporation mermed trademark terumo corporation fred registered trademark microvention inc scepter trademark microvention inc mirasol registered trademark terumo bct biotechnology llc spectrum optia trademark terumo bct inc terumo corporation annual report reporting policy corporate mission report created intuitively share information stakeholder terumos business activity conducted corporate mission contributing society healthcare promote communication society feature introduces initiative developing endovascular treatment apheresis therapy illustrate terumos stance realizing corporate philosophy moreover starting fiscal year new section environmental health safety ehs added report content scope report report carry data terumo group company japan overseas presented consolidated basis wherever possible albeit exception depending data item report period fiscal april march activity reported include recent activity publication schedule report july previous report august next report august tentative referenced guideline gri sustainability reporting guideline standard disclosure japanese ministry environment environmental reporting guideline version report archive past report year available pdf format web site terumo corporation annual report tokyo office terumo corporation october tokyo opera city tower nishishinjuku shinjukuku tokyo japan printed japan